<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Pharmaceutics</journal-id><journal-id journal-id-type="iso-abbrev">Pharmaceutics</journal-id><journal-id journal-id-type="publisher-id">pharmaceutics</journal-id><journal-title-group><journal-title>Pharmaceutics</journal-title></journal-title-group><issn pub-type="epub">1999-4923</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40006523</article-id><article-id pub-id-type="pmc">PMC11859714</article-id><article-id pub-id-type="doi">10.3390/pharmaceutics17020156</article-id><article-id pub-id-type="publisher-id">pharmaceutics-17-00156</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Pesticides&#x02019; Cornea Permeability&#x02014;How Serious Is This Problem?</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-1846-9240</contrib-id><name><surname>Soba&#x00144;ska</surname><given-names>Anna W.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x02013; original draft</role><xref rid="af1-pharmaceutics-17-00156" ref-type="aff">1</xref><xref rid="c1-pharmaceutics-17-00156" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0006-7544-365X</contrib-id><name><surname>Soba&#x00144;ski</surname><given-names>Andrzej M.</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af2-pharmaceutics-17-00156" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7764-4993</contrib-id><name><surname>Wanat</surname><given-names>Karolina</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af1-pharmaceutics-17-00156" ref-type="aff">1</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>L&#x000f6;benberg</surname><given-names>Raimar</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-pharmaceutics-17-00156"><label>1</label>Department of Analytical Chemistry, Medical University of Lodz, Muszynskiego 1, 90-151 Lodz, Poland; <email>karolina.wanat@umed.lodz.pl</email></aff><aff id="af2-pharmaceutics-17-00156"><label>2</label>Faculty of Chemistry, University of Lodz, Tamka 12, 91-403 Lodz, Poland; <email>andrzej.sobanski@edu.uni.lodz.pl</email></aff><author-notes><corresp id="c1-pharmaceutics-17-00156"><label>*</label>Correspondence: <email>anna.sobanska@umed.lodz.pl</email></corresp></author-notes><pub-date pub-type="epub"><day>24</day><month>1</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>17</volume><issue>2</issue><elocation-id>156</elocation-id><history><date date-type="received"><day>19</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>20</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>22</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p><bold>Background:</bold> A total of 348 pesticides from different chemical families (carbamates, organochlorines organophosphorus compounds, pyrethroids, triazines and miscellaneous) were investigated in the context of their cornea permeability and potential to cause eye corrosion. <bold>Methods:</bold> Multivariate models of cornea permeability based on compounds whose cornea permeability has been determined experimentally were proposed. The models, applicable to compounds across a relatively broad lipophilicity range (e.g., pesticides with octanol&#x02013;water partition coefficient log <bold><italic toggle="yes">P</italic></bold> up to ca. 8), assume a reverse-parabolic relationship between cornea permeability and lipophilicity, expressed as <bold><italic toggle="yes">XLOGP3</italic></bold>; other main descriptors present in the models are log <bold><italic toggle="yes">D</italic></bold> at pH 7.4 and polar surface area (<bold><italic toggle="yes">PSA</italic></bold>). <bold>Results:</bold> It appears that the trans-corneal transport of all studied pesticides is possible to some degree; however, it is more difficult for the majority of highly lipophilic pesticides from the organochlorine and pyrethroid families. The same set of 348 pesticides was also evaluated for their eye-corrosive potential using novel artificial neural network models involving simple physico-chemical properties of the compounds (lipophilicity, aqueous solubility, polar surface area, H-bond donor and acceptor count and the count of atoms such as N, NH, O, P, S and halogens). <bold>Conclusions:</bold> It was concluded that eye corrosion is an issue, especially among the pesticides from organochlorine and organophosphorus families.</p></abstract><kwd-group><kwd>cornea permeability</kwd><kwd>MLR models</kwd><kwd>ANN models</kwd><kwd>eye corrosion</kwd><kwd>pesticides</kwd></kwd-group><funding-group><award-group><funding-source>Medical University of Lodz</funding-source><award-id>503/3-016-03/503-31-001</award-id></award-group><funding-statement>This research study was supported by an internal grant of the Medical University of Lodz, no. 503/3-016-03/503-31-001.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-pharmaceutics-17-00156"><title>1. Introduction</title><p>The cornea is the outermost layer of the eye, controlling the entry of light into the eye and shielding the inner parts of the eyeball against germs, dust and other harmful factors [<xref rid="B1-pharmaceutics-17-00156" ref-type="bibr">1</xref>]. It consists of three main layers: endothelium, stroma and epithelium. One of them&#x02014;the endothelium&#x02014;plays no significant role in preventing compounds&#x02019; passage across the cornea; it is a monolayer of hexagonal cells that can be crossed either by a paracellular or transcellular route, favored by hydrophilic/ionic and lipophilic compounds, respectively [<xref rid="B2-pharmaceutics-17-00156" ref-type="bibr">2</xref>]. The other cornea layers are rate-limiting barriers for lipophilic (aqueous stroma) and hydrophilic (lipophilic corneal epithelium) compounds, respectively. Ophthalmic drugs, if they are to be administered the easiest way&#x02014;as eyedrops or ointments&#x02014;should be able to cross the cornea; compounds that are not absorbed via the cornea may enter the eye through the conjunctiva, but this is a minor route, available for large, hydrophilic molecules (e.g., peptides or proteins) [<xref rid="B3-pharmaceutics-17-00156" ref-type="bibr">3</xref>]. If the corneal permeability of typical, small-molecule drugs is too low and they cannot achieve required concentrations in the eye, they may be taken systemically (in relatively high doses to account for the drugs&#x02019; metabolism and distribution in other tissues and with all possible side effects) or by intravitreal injections; in the latter case, drugs (used, e.g., for macular degeneration) are injected directly into the eyeball, which is also associated with some potential side effects, especially after repeated applications [<xref rid="B4-pharmaceutics-17-00156" ref-type="bibr">4</xref>]. Some drugs may be administered by periocular routes to different spots in the area immediately surrounding the eye, which reduces the risks associated with intravitreal injections and systemic administration [<xref rid="B5-pharmaceutics-17-00156" ref-type="bibr">5</xref>]. Following periocular delivery, compounds move to the sclera and undergo transscleral absorption [<xref rid="B4-pharmaceutics-17-00156" ref-type="bibr">4</xref>] (a detailed review of the permeability of the sclera, conjunctiva and different layers of the cornea to small groups of compounds is given in ref. [<xref rid="B6-pharmaceutics-17-00156" ref-type="bibr">6</xref>]).</p><p>Factors that influence the passage of compounds across the cornea are physiological, physico-chemical and formulation-related. In drug design, the main focus is on the physico-chemical properties of drug candidates to facilitate trans-corneal absorption. Early observations pointed to the relationship between the chain length and the corneal permeability for n-alkyl p-aminobenzoate esters [<xref rid="B7-pharmaceutics-17-00156" ref-type="bibr">7</xref>]. As early as the 1970s and 1980s, it was also established that the corneal permeability of drugs depends on their lipophilicity and this relationship is either parabolic, with the maximum permeability at log <bold><italic toggle="yes">P</italic></bold> (or log <bold><italic toggle="yes">D</italic></bold>) between 2 and 3 [<xref rid="B8-pharmaceutics-17-00156" ref-type="bibr">8</xref>,<xref rid="B9-pharmaceutics-17-00156" ref-type="bibr">9</xref>], or sigmoidal [<xref rid="B10-pharmaceutics-17-00156" ref-type="bibr">10</xref>,<xref rid="B11-pharmaceutics-17-00156" ref-type="bibr">11</xref>]. Later, it was discovered that other physico-chemical properties are also of importance [<xref rid="B12-pharmaceutics-17-00156" ref-type="bibr">12</xref>,<xref rid="B13-pharmaceutics-17-00156" ref-type="bibr">13</xref>]. New &#x0201c;Rules of Thumb&#x0201d; for ophthalmic drugs have been proposed recently and the physico-chemical parameters found to facilitate drugs&#x02019; topical ophthalmic delivery are the distribution coefficient at physiological pH, topological polar surface area and free energy of octanol&#x02013;water distribution below certain limits (clog <bold><italic toggle="yes">D</italic></bold><sub>pH7.4</sub> &#x0003c; 4.0; <bold><italic toggle="yes">TPSA</italic></bold> &#x0003c; 250 &#x000c5;<sup>2</sup>; &#x00394;<bold><italic toggle="yes">G</italic></bold><sub>o/w</sub> &#x0003c; 20 kJ/mol) and sufficient aqueous solubility (&#x0003e;1 mM) [<xref rid="B14-pharmaceutics-17-00156" ref-type="bibr">14</xref>].</p><p>Due to the asymmetry in the cornea structure, the transport of compounds across the cornea (inwards/outwards) is also asymmetrical, with additional phenomena such as tear drainage reducing compounds&#x02019; eye penetration [<xref rid="B13-pharmaceutics-17-00156" ref-type="bibr">13</xref>,<xref rid="B15-pharmaceutics-17-00156" ref-type="bibr">15</xref>]; in the case of drugs, not more than 5% of the applied dose reaches the intraocular tissues [<xref rid="B3-pharmaceutics-17-00156" ref-type="bibr">3</xref>]. Compounds that reach the vitreous cavity are eliminated via blood&#x02013;ocular barriers (blood&#x02013;aqueous and blood&#x02013;retinal barriers) [<xref rid="B16-pharmaceutics-17-00156" ref-type="bibr">16</xref>,<xref rid="B17-pharmaceutics-17-00156" ref-type="bibr">17</xref>].</p><p>Drug candidates can be examined for their corneal permeability by animal experiments in vivo [<xref rid="B18-pharmaceutics-17-00156" ref-type="bibr">18</xref>] and ex vivo animal models [<xref rid="B11-pharmaceutics-17-00156" ref-type="bibr">11</xref>,<xref rid="B19-pharmaceutics-17-00156" ref-type="bibr">19</xref>,<xref rid="B20-pharmaceutics-17-00156" ref-type="bibr">20</xref>,<xref rid="B21-pharmaceutics-17-00156" ref-type="bibr">21</xref>,<xref rid="B22-pharmaceutics-17-00156" ref-type="bibr">22</xref>,<xref rid="B23-pharmaceutics-17-00156" ref-type="bibr">23</xref>] or, to avoid ethical controversies, the ability of compounds to cross the cornea can be studied in vitro&#x02014;by cell/tissue-based assays [<xref rid="B24-pharmaceutics-17-00156" ref-type="bibr">24</xref>,<xref rid="B25-pharmaceutics-17-00156" ref-type="bibr">25</xref>,<xref rid="B26-pharmaceutics-17-00156" ref-type="bibr">26</xref>,<xref rid="B27-pharmaceutics-17-00156" ref-type="bibr">27</xref>,<xref rid="B28-pharmaceutics-17-00156" ref-type="bibr">28</xref>] or by non-cell-based methods, e.g., the parallel artificial membrane permeability assay (PAMPA) [<xref rid="B29-pharmaceutics-17-00156" ref-type="bibr">29</xref>] or liquid chromatographic models [<xref rid="B30-pharmaceutics-17-00156" ref-type="bibr">30</xref>,<xref rid="B31-pharmaceutics-17-00156" ref-type="bibr">31</xref>]&#x02014;or in silico [<xref rid="B1-pharmaceutics-17-00156" ref-type="bibr">1</xref>,<xref rid="B11-pharmaceutics-17-00156" ref-type="bibr">11</xref>,<xref rid="B32-pharmaceutics-17-00156" ref-type="bibr">32</xref>,<xref rid="B33-pharmaceutics-17-00156" ref-type="bibr">33</xref>,<xref rid="B34-pharmaceutics-17-00156" ref-type="bibr">34</xref>,<xref rid="B35-pharmaceutics-17-00156" ref-type="bibr">35</xref>,<xref rid="B36-pharmaceutics-17-00156" ref-type="bibr">36</xref>,<xref rid="B37-pharmaceutics-17-00156" ref-type="bibr">37</xref>,<xref rid="B38-pharmaceutics-17-00156" ref-type="bibr">38</xref>,<xref rid="B39-pharmaceutics-17-00156" ref-type="bibr">39</xref>,<xref rid="B40-pharmaceutics-17-00156" ref-type="bibr">40</xref>].</p><p>At present, a lot of attention is being given to the ocular toxicity of environmental contaminants contributing to ophthalmic conditions such as eye irritation, dry eye syndrome, etc. Anthropogenic chemicals from both civilian and military sources (e.g., contaminants from burn pits and train derailment; riot control agents; illicit drugs; herbicides, etc.) were reviewed in relation to the eye, and their negative influence upon different eye elements (cornea, retina or optic nerve) after topical and systemic exposures was discussed [<xref rid="B41-pharmaceutics-17-00156" ref-type="bibr">41</xref>,<xref rid="B42-pharmaceutics-17-00156" ref-type="bibr">42</xref>,<xref rid="B43-pharmaceutics-17-00156" ref-type="bibr">43</xref>,<xref rid="B44-pharmaceutics-17-00156" ref-type="bibr">44</xref>].</p><p>The objective of this study is to assess the ability of an important class of environmental pollutants&#x02014;pesticides&#x02014;to cross the cornea and to evaluate compounds from this group as possible causes of eye corrosion using novel in silico methods based on experimental data.</p></sec><sec id="sec2-pharmaceutics-17-00156"><title>2. Materials and Methods</title><sec id="sec2dot1-pharmaceutics-17-00156"><title>2.1. Reference Compounds</title><p>Compounds <bold>1</bold> to <bold>90</bold>, along with their experimental corneal permeability coefficients, log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub>, were taken from [<xref rid="B1-pharmaceutics-17-00156" ref-type="bibr">1</xref>,<xref rid="B6-pharmaceutics-17-00156" ref-type="bibr">6</xref>,<xref rid="B34-pharmaceutics-17-00156" ref-type="bibr">34</xref>]. Compounds <bold>91</bold> to <bold>2389</bold>, with experimental data related to eye corrosion used to train, test and validate models of eye-corrosive activity, were taken from [<xref rid="B45-pharmaceutics-17-00156" ref-type="bibr">45</xref>].</p></sec><sec id="sec2dot2-pharmaceutics-17-00156"><title>2.2. Molecular Descriptors</title><p>Electrotopological state indices [<xref rid="B46-pharmaceutics-17-00156" ref-type="bibr">46</xref>,<xref rid="B47-pharmaceutics-17-00156" ref-type="bibr">47</xref>], polar surface area (<bold><italic toggle="yes">PSA</italic></bold>), counts of particular atoms (<bold><italic toggle="yes">NH</italic></bold>, <bold><italic toggle="yes">O</italic></bold>, <bold><italic toggle="yes">N</italic></bold>, <bold><italic toggle="yes">DONORS</italic></bold>, <bold><italic toggle="yes">ACCEPTORS</italic></bold>, <bold><italic toggle="yes">HALOG</italic></bold>, <bold><italic toggle="yes">P</italic></bold> and <bold><italic toggle="yes">S</italic></bold>), aqueous solubility (<bold><italic toggle="yes">ALogPS_logS</italic></bold>) and octanol&#x02013;water partition coefficients (<bold><italic toggle="yes">ALogPS_logP</italic></bold>) were calculated online using the OChem platform (<uri xlink:href="https://ochem.eu">https://ochem.eu</uri>, accessed on 30 November 2024). Octanol&#x02013;water distribution coefficient at pH = 7.4 (log <bold><italic toggle="yes">D</italic></bold><sub>ACD</sub>) were calculated using ACDLabs software (Version 7.0). Octanol&#x02013;water partition coefficients were also calculated using ACDLabs software (log <bold><italic toggle="yes">P</italic></bold><sub>ACD</sub>) and SwissADME software (<uri xlink:href="http://www.swissadme.ch/">http://www.swissadme.ch/</uri>, accessed on 30 November 2024) [<xref rid="B48-pharmaceutics-17-00156" ref-type="bibr">48</xref>] (<bold><italic toggle="yes">XLOGP3</italic></bold>, <bold><italic toggle="yes">iLOGP</italic></bold>, <bold><italic toggle="yes">MLOGP</italic></bold>, <bold><italic toggle="yes">WLOGP</italic></bold>, <bold><italic toggle="yes">Silicos-IT Log P</italic></bold> and <bold><italic toggle="yes">Consensus Log P</italic></bold>). Molecular properties of the studied compounds, including molecular weight (<bold><italic toggle="yes">MW</italic></bold>), volume (<bold><italic toggle="yes">Vol</italic></bold>), H-bond donor count (<bold><italic toggle="yes">nHD</italic></bold>), H-bond acceptor count (<bold><italic toggle="yes">nHA</italic></bold>), formal charge (<bold><italic toggle="yes">fChar</italic></bold>), rigid bond count (<bold><italic toggle="yes">nRig</italic></bold>), rotatable bond count (<bold><italic toggle="yes">nRot</italic></bold>), flexibility = <bold><italic toggle="yes">nRot</italic></bold>/<bold><italic toggle="yes">nRig</italic></bold> (<bold><italic toggle="yes">Flex</italic></bold>), stereocenter count (<bold><italic toggle="yes">nStereo</italic></bold>), maximum ring size (<bold><italic toggle="yes">MaxRing</italic></bold>), number of heteroatoms, i.e., non-carbon atoms including hydrogens (<bold><italic toggle="yes">nHet</italic></bold>)<bold>, </bold> fraction of sp<sup>3</sup> carbons (<bold><italic toggle="yes">F<sub>Csp3</sub></italic></bold>) and topological surface area (<bold><italic toggle="yes">TPSA</italic></bold>), were computed using ADMETlab3.0 software (<uri xlink:href="https://admetlab3.scbdd.com/">https://admetlab3.scbdd.com/</uri>, accessed on 30 November 2024) [<xref rid="B49-pharmaceutics-17-00156" ref-type="bibr">49</xref>]. Predicted absorption properties, including parallel artificial membrane permeability assay (<bold><italic toggle="yes">PAMPA</italic></bold>), Madin&#x02212;Darby canine kidney cells&#x02019; logarithmic permeability coefficient (<bold><italic toggle="yes">MDCK</italic></bold>) and the human colon adenocarcinoma cell lines&#x02019; permeability (<bold><italic toggle="yes">Caco-2</italic></bold>) were also calculated using ADMETlab3.0 software.</p></sec><sec id="sec2dot3-pharmaceutics-17-00156"><title>2.3. Multiple Linear Regression (MLR) Models of Corneal Permeability</title><p>Compounds <bold>1</bold> to <bold>60</bold> were used as a training set and <bold>61</bold> to <bold>90</bold> as a test set. MLR models were generated using XLSTAT (Lumivero (2025) XLSTAT statistical and data analysis solution, <uri xlink:href="https://www.xlstat.com/en">https://www.xlstat.com/en</uri>). Descriptors with zero variability were removed manually and the suitable descriptors for MLR models were selected using stepwise regression, in forward mode. Equations (8), (9) and (14)&#x02013;(16) were subjected to internal and external validation using the following metrics: determination coefficient of the training set (R<sup>2</sup>); root mean square error of leave-many-out (LMO) cross-validation (5-fold; RMSECV); root mean square error of external prediction (RMSEP); and cross-validated R<sup>2</sup> (Q<sup>2</sup>) [<xref rid="B50-pharmaceutics-17-00156" ref-type="bibr">50</xref>,<xref rid="B51-pharmaceutics-17-00156" ref-type="bibr">51</xref>].</p></sec><sec id="sec2dot4-pharmaceutics-17-00156"><title>2.4. Artificial Neural Network (ANN) Classification of Pesticides with High (1) and Low (0) Risk of Eye Corrosion</title><p><italic toggle="yes">Compounds</italic>&#x000a0;<bold>91</bold> to <bold>2389</bold> were randomly divided into three sets for training, testing and validation (70, 15 and 15% of the whole set, respectively), as indicated in the <xref rid="app1-pharmaceutics-17-00156" ref-type="app">Supplementary Materials</xref>. Multilayer perceptron (MLP) artificial neural networks (ANNs) were generated using Statistica v. 13.3 (classification mode, Automated Network Search (ANS) module, 100 networks to train, 5 networks to retain). The possible neuron activation functions were as follows: identity, logistic, hyperbolic tangent and exponential. The BFGS (Broyden&#x02013;Fletcher&#x02013;Goldfarb&#x02013;Shanno) algorithm was used to train the network together with the sum of squares (SOS) or entropy error function. After the networks were generated, all independent variables were examined using their Global Sensitivity Analysis scores to check if they are of sufficient importance to remain in the model (GSA scores rate the contribution of particular variables to the dependent variable being modeled; variables with GSA scores below 1 are redundant, as the model performs equally well or better without them).</p></sec></sec><sec sec-type="results" id="sec3-pharmaceutics-17-00156"><title>3. Results and Discussion</title><sec id="sec3dot1-pharmaceutics-17-00156"><title>3.1. Cornea Permeability</title><p>It was reported in 1979 that the corneal permeability of PABA esters depends on the number of carbon atoms in the n-alkyl chain (and this relationship is reverse parabolic, with the maximum cornea permeability obtained for the propyl ester) [<xref rid="B7-pharmaceutics-17-00156" ref-type="bibr">7</xref>]. Following this observation, the relationships between cornea permeability and different physico-chemical properties of compounds have been studied extensively. The cornea permeability of compounds has been predicted using the QSAR methodology by several authors thus far, with the most distinguished models listed below in Equation (1) [<xref rid="B1-pharmaceutics-17-00156" ref-type="bibr">1</xref>], Equations (2) and (3) [<xref rid="B37-pharmaceutics-17-00156" ref-type="bibr">37</xref>], Equations (4) and (5) [<xref rid="B31-pharmaceutics-17-00156" ref-type="bibr">31</xref>], Equation (6) [<xref rid="B38-pharmaceutics-17-00156" ref-type="bibr">38</xref>] and Equation (7) [<xref rid="B40-pharmaceutics-17-00156" ref-type="bibr">40</xref>]:<disp-formula>log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> = &#x02212;0.005 <bold><italic toggle="yes">MW</italic></bold> &#x02212; 0.166 <bold><italic toggle="yes">HBD</italic></bold> &#x02212; 0.081 (&#x000b1;0.075) <bold><italic toggle="yes">nHA</italic></bold> + 0.164 log <bold><italic toggle="yes">P</italic></bold> + 0.209 log <bold><italic toggle="yes">D</italic></bold> &#x02212; 5.994 <bold><italic toggle="yes">&#x00131;H(max)</italic></bold> &#x02212; 3.740 <break/>(n = 47, R<bold><sup>2</sup></bold> = 0.77)<label>(1)</label></disp-formula><disp-formula>log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> = 0.390 log <bold><italic toggle="yes">P</italic></bold> &#x02212; 0.00327 <bold><italic toggle="yes">MW</italic></bold> &#x02212; 4.77 (n = 105, R<sup>2</sup> = 0.51)<label>(2)</label></disp-formula><disp-formula>log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> = 0.230 log <bold><italic toggle="yes">P</italic></bold> &#x02212; 0.0679 <bold><italic toggle="yes">n<sub>H</sub></italic></bold> &#x02212; 0.168 <bold><italic toggle="yes">&#x003ba;</italic><italic toggle="yes">3</italic></bold> &#x02212; 4.35 (n = 95, R<sup>2</sup> = 0.52)<label>(3)</label></disp-formula><disp-formula>log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> = &#x02212;4.4 + 0.83 log <bold><italic toggle="yes">k</italic></bold><sub>BMC</sub> &#x02212; 0.0044 <bold><italic toggle="yes">MW</italic></bold> (n = 38, R<sup>2</sup> = 0.80)<label>(4)</label></disp-formula><disp-formula>log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> = &#x02212;4.0 + 0.25 log <bold><italic toggle="yes">D</italic></bold> &#x02212; 0.0040 <bold><italic toggle="yes">MW</italic></bold> (n = 38, R<sup>2</sup> = 0.57)<label>(5)</label></disp-formula><disp-formula>log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> = &#x02212;5.566 <bold><italic toggle="yes">Q</italic></bold><sub>H</sub> 2 + 3.027 <bold><italic toggle="yes">Q</italic></bold><sub>H</sub> &#x02212; 0.155 <bold><italic toggle="yes">Q</italic></bold><sub>O,N</sub> &#x02212; 9.413 &#x000d7; 10<sup>&#x02212;4</sup>&#x000a0;<bold><italic toggle="yes">V</italic></bold> &#x02212; 4.278 (n = 30, R<sup>2</sup> = 0.85)<label>(6)</label></disp-formula><disp-formula>log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> = &#x02212;3.885 &#x02212; 0.183 <bold><italic toggle="yes">nHB</italic></bold><sub>tot</sub> + 0.277 log <bold><italic toggle="yes">D</italic></bold> (n = 58, R<sup>2</sup> = 0.78)<label>(7)</label></disp-formula></p><p>Equations (1)&#x02013;(7) are related to skin permeability models developed by Potts and Guy [<xref rid="B52-pharmaceutics-17-00156" ref-type="bibr">52</xref>,<xref rid="B53-pharmaceutics-17-00156" ref-type="bibr">53</xref>], who stressed the positive, linear correlation between compounds&#x02019; lipophilicity and skin permeability and who also reported the negative influence of molecules&#x02019; size (volume or weight) and the ability to form H-bonds (H-bond donor and acceptor count, and total H-bond count) on their transdermal absorption. Unfortunately, Equations (1)&#x02013;(7), however valuable, also have certain disadvantages: (i) they have moderate statistics and (ii) the majority of them were developed based on small groups of structurally related compounds (mainly small-molecule drugs), whose physico-chemical properties are within narrow ranges [<xref rid="B14-pharmaceutics-17-00156" ref-type="bibr">14</xref>], which, as it may be expected, also makes their application domains rather narrow. With these considerations in mind and with the focus on pesticides from several very different chemical families, we have decided to develop new models that are more suitable for compounds with diverse physico-chemical properties. Our attention turned at first to refining existing models based on the linear relationships between log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> and log <bold><italic toggle="yes">P</italic></bold>/log <bold><italic toggle="yes">D</italic></bold>; two multivariate linear (MLR) equations, Equation (8) and a simplified Equation (9), generated in the process are given below (<xref rid="pharmaceutics-17-00156-f001" ref-type="fig">Figure 1</xref> and <xref rid="pharmaceutics-17-00156-f002" ref-type="fig">Figure 2</xref>):<disp-formula>log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> = &#x02212;4.198 (&#x000b1;0.184) + 0.159 (&#x000b1;0.047) log <bold><italic toggle="yes">D</italic></bold><sub>ACD</sub> &#x02212; 0.0164 (&#x000b1;0.0026) <bold><italic toggle="yes">PSA</italic></bold> + 0.206 (&#x000b1;0.048) <bold><italic toggle="yes">XLOGP3</italic></bold> &#x02212; <break/>0.0397 (&#x000b1;0.0139) <bold><italic toggle="yes">SaaCH</italic></bold> + 0.333 (&#x000b1;0.113) <bold><italic toggle="yes">Se1C1C3a</italic></bold> + 0.0522 (&#x000b1;0.0256) <bold><italic toggle="yes">SsNH2</italic></bold><break/> (n = 60, R<sup>2</sup> = 0.813, R<sup>2</sup><sub>adj.</sub> = 0.792, F = 38.49, <italic toggle="yes">p</italic> &#x0003c; 0.01, RMSECV = 0.357, RMSEP = 0.511, Q<sup>2</sup> = 0.765)<label>(8)</label></disp-formula>
<disp-formula>log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> = &#x02212;4.366 (&#x000b1;0.169) + 0.209 (&#x000b1;0.045) log <bold><italic toggle="yes">D</italic></bold><sub>ACD</sub> &#x02212; 0.0125 (&#x000b1;0.0017) <bold><italic toggle="yes">PSA</italic></bold> + 0.179 (&#x000b1;0.052) <bold><italic toggle="yes">XLOGP3</italic></bold> &#x02212; <break/>0.0319 (&#x000b1;0.0150) <bold><italic toggle="yes">SaaCH</italic></bold><break/> (n = 60, R<sup>2</sup> = 0.769, R<sup>2</sup><sub>adj.</sub> = 0.752, F = 45.84, <italic toggle="yes">p</italic> &#x0003c; 0.01, RMSECV = 0.394, RMSEP = 0.452, Q<sup>2</sup> = 0.722)<label>(9)</label></disp-formula></p><p>Despite their relatively good statistical parameters (including the results of external validation), Equations (8) and (9) were found to be unsatisfactory in the context of their applicability to studied pesticides. The results of log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> calculations based on Equations (8) and (9) returned suspiciously high results (pointing to very good trans-corneal absorption) for more lipophilic pesticides, especially from the organochlorine and pyrethroid families.</p><p>At this point, the decision was made to improve the models by using polynomial expressions. This approach was inspired by some already mentioned early reports on the on-linear relationships between cornea permeability and the lipophilicity-related parameters of compounds: (i) the chain length for n-alkyl p-aminobenzoate esters [<xref rid="B7-pharmaceutics-17-00156" ref-type="bibr">7</xref>] and (ii) log <bold><italic toggle="yes">D</italic></bold> or log <bold><italic toggle="yes">P</italic></bold> [<xref rid="B8-pharmaceutics-17-00156" ref-type="bibr">8</xref>,<xref rid="B9-pharmaceutics-17-00156" ref-type="bibr">9</xref>,<xref rid="B39-pharmaceutics-17-00156" ref-type="bibr">39</xref>]. Schoenwald and Huang experimented with quadratic functions of lipophilicity, also incorporating the logarithm of molecular weight (log <bold><italic toggle="yes">MW</italic></bold>)&#x02014;the latter was reversely correlated with permeability. They also studied the effects of ionization in the context of trans-corneal transport and proposed equations involving the degree of ionization (log <bold><italic toggle="yes">DI</italic></bold>) or the distribution coefficient (log <bold><italic toggle="yes">D</italic></bold>) instead of the partition coefficient (log <bold><italic toggle="yes">P</italic></bold>) (Equations (10) and (11)), discovering that for a small group of structurally similar compounds, the effect of log <bold><italic toggle="yes">MW</italic></bold> is negligible and the quadratic function of log <bold><italic toggle="yes">D</italic></bold> accounts for ca. 95% of the total log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> variability [<xref rid="B9-pharmaceutics-17-00156" ref-type="bibr">9</xref>]. However, later studies revealed that log <bold><italic toggle="yes">D</italic></bold> used on its own is not sufficient as a cornea permeability predictor for larger sets of more structurally diverse drugs [<xref rid="B39-pharmaceutics-17-00156" ref-type="bibr">39</xref>].<disp-formula>log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> = 1.01 log <bold><italic toggle="yes">P</italic></bold> &#x02212; 0.115 (log <bold><italic toggle="yes">P</italic></bold>)<sup>2</sup> &#x02212; 5.64 log <bold><italic toggle="yes">MW</italic></bold> &#x02212; 10.4 log <bold><italic toggle="yes">DI</italic></bold> + 7.27 (n = 12, R<sup>2</sup> = 0.860)<label>(10)</label></disp-formula><disp-formula>log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> = 0.646 log <bold><italic toggle="yes">D</italic></bold> &#x02212; 0.101 (log <bold><italic toggle="yes">D</italic></bold>)<sup>2</sup> &#x02212; 4.891 log <bold><italic toggle="yes">MW</italic></bold> + 6.907 (n = 12, R<sup>2</sup> = 0.851)<label>(11)</label></disp-formula><disp-formula>log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> = &#x02212;0.071 (log <bold><italic toggle="yes">D</italic></bold>)<sup>2</sup> + 0.465 log <bold><italic toggle="yes">D</italic></bold> &#x02212; 5.265 (n = 23, R<sup>2</sup> = 0.621)<label>(12)</label></disp-formula><disp-formula>log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> = &#x02212;0.084(log <bold><italic toggle="yes">D</italic></bold>)<sup>2</sup> + 0.464 log <bold><italic toggle="yes">D</italic></bold> &#x02212; 5.170 (n = 22, R<sup>2</sup> = 0.663)<label>(13)</label></disp-formula></p><p>Equations (10)&#x02013;(13) explain the existence of a plateau for log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> = f (lipophilicity) dependencies observed at log <bold><italic toggle="yes">P</italic></bold>/log <bold><italic toggle="yes">D</italic></bold> = ca. 3, but they have not been tested on compounds with log <bold><italic toggle="yes">D</italic></bold> &#x0003e; 4; in fact, the majority of compounds used to develop known models of cornea permeability are small, drug-like molecules, usually meeting the requirements formulated by Karami [<xref rid="B14-pharmaceutics-17-00156" ref-type="bibr">14</xref>]. However, non-linear (e.g., reverse-parabolic or Gaussian-shaped) relationships between the compounds&#x02019; lipophilicity and absorption/bioavailability have been proposed, e.g., for skin permeability, PAMPA permeability [<xref rid="B54-pharmaceutics-17-00156" ref-type="bibr">54</xref>] or half-maximum inhibitory concentrations (IC50s) [<xref rid="B55-pharmaceutics-17-00156" ref-type="bibr">55</xref>] of different groups of drugs. The non-linearity of relationships between the studied property and the lipophilicity is especially pronounced for the bioconcentration factor in aquatic organisms (<bold><italic toggle="yes">BCF</italic></bold>). The physico-chemical properties of environmental pollutants are much more diverse than those of drugs, and experimental <bold><italic toggle="yes">BCF</italic></bold> values are available for a significant number of compounds over a very broad lipophilicity range [<xref rid="B56-pharmaceutics-17-00156" ref-type="bibr">56</xref>]. It was found that log <bold><italic toggle="yes">BCF</italic></bold> is relatively stable for highly hydrophilic compounds (log <bold><italic toggle="yes">P</italic></bold> &#x0003c; 1), increases proportionally to lipophilicity for log <bold><italic toggle="yes">P</italic></bold> between 1 and ca. 7 and is reversely proportional to lipophilicity for log <bold><italic toggle="yes">P</italic></bold> between 7 and 10, with some negative influence found for molecular size [<xref rid="B57-pharmaceutics-17-00156" ref-type="bibr">57</xref>,<xref rid="B58-pharmaceutics-17-00156" ref-type="bibr">58</xref>]; for very highly lipophilic compounds (log <bold><italic toggle="yes">P</italic></bold> &#x0003e; 10), the log <bold><italic toggle="yes">BCF</italic></bold>&#x02013;lipophilicity relationship is likely to reach another plateau, but experimental <bold><italic toggle="yes">BCF</italic></bold> data to support this view are limited.</p><p>As many pesticides investigated in this study are relatively lipophilic (with log <bold><italic toggle="yes">P</italic></bold> up to ca. 8), we suspected that (by analogy to other absorption/transport processes mentioned above) very high <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> values obtained for them using Equations (8) and (9) may be artifacts. We sought to account for the possible reduction in cornea permeability for highly lipophilic molecules by introducing non-linear cornea permeability&#x02013;lipophilicity dependencies. Different calculated lipophilicity parameters and their squared values were investigated (<bold><italic toggle="yes">MLOGP</italic></bold>, <bold><italic toggle="yes">WLOGP</italic></bold>, <italic toggle="yes"><bold>iLOGP</bold></italic>, log <bold><italic toggle="yes">P</italic></bold><sub>ACD</sub>, log <bold><italic toggle="yes">P</italic></bold><sub>3.0</sub>, <bold><italic toggle="yes">Silicos-IT</italic></bold>&#x000a0;<italic toggle="yes"><bold>Log P</bold></italic>, <bold><italic toggle="yes">Consensus</italic></bold>&#x000a0;<italic toggle="yes"><bold>Log P</bold></italic> and <italic toggle="yes"><bold>ALogPS_logP</bold></italic>). It was determined that the best models (based on independent variables selected by forward stepwise regression, characterized by satisfying statistical parameters and, on the other hand, returning plausible log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> values for studied pesticides) involve log <bold><italic toggle="yes">D</italic></bold><sub>ACD</sub> (at pH = 7.4), <bold><italic toggle="yes">XLOGP3</italic></bold> and a quadratic term (<bold><italic toggle="yes">XLOGP3</italic></bold>)<sup>2</sup>. However, combined log <bold><italic toggle="yes">D</italic></bold><sub>ACD</sub>, <bold><italic toggle="yes">XLOGP3</italic></bold> and (<bold><italic toggle="yes">XLOGP3</italic></bold>)<sup>2</sup> account for only ca. 57% of total log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> variability, so additional independent variables were incorporated to produce Equations (14) and (15) presented below, which also include (i) <bold><italic toggle="yes">PSA</italic></bold> and electrotopological indices <bold><italic toggle="yes">Se1C3O1d</italic></bold> and <bold><italic toggle="yes">SsNH2</italic></bold> (Equation (14), <xref rid="pharmaceutics-17-00156-f003" ref-type="fig">Figure 3</xref>) and (ii) <bold><italic toggle="yes">PSA</italic></bold>, calculated <bold><italic toggle="yes">caco-2</italic></bold> and <bold><italic toggle="yes">MDCK</italic></bold> permeabilities (Equation (15), <xref rid="pharmaceutics-17-00156-f004" ref-type="fig">Figure 4</xref>).<disp-formula>log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> = &#x02212;4.514 (&#x000b1;0.160) + 0.202 (&#x000b1;0.044) log <bold><italic toggle="yes">D</italic></bold><sub>ACD</sub> + 0.477 (&#x000b1;0.081) <bold><italic toggle="yes">XLOGP3</italic></bold> &#x02212; 0.0163 (&#x000b1;0.0024) <bold><italic toggle="yes">PSA</italic></bold> &#x02212; 0.103 <break/>(&#x000b1;0.023) (<bold><italic toggle="yes">XLOGP3</italic></bold>)<sup>2</sup> + 0.0627 (&#x000b1;0.0270) <bold><italic toggle="yes">SsNH2</italic></bold> + 0.0853 (&#x000b1;0.0253) <bold><italic toggle="yes">Se1C3O1d</italic></bold> (n = 60, R<sup>2</sup> = 0.836, R<sup>2</sup><sub>adj.</sub> = 0.818, <break/>F = 45.16, <italic toggle="yes">p</italic> &#x0003c; 0.01, RMSECV = 0.366, RMSEP = 0.415, Q<sup>2</sup> = 0.792)<label>(14)</label></disp-formula><disp-formula>log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> = &#x02212;6.365 (&#x000b1;0.954) + 0.244 (&#x000b1;0.040) log <bold><italic toggle="yes">D</italic></bold><sub>ACD</sub> + 0.382 (&#x000b1;0.084) <bold><italic toggle="yes">XLOGP3</italic></bold> &#x02212; 0.0911 (&#x000b1;0.0235) (<bold><italic toggle="yes">XLOGP3</italic></bold>)<sup>2</sup>
<break/>&#x02212; 0.00985 (0.00197) <bold><italic toggle="yes">PSA</italic></bold> + 0.347 (&#x000b1;0.167) <bold><italic toggle="yes">caco-2</italic></bold> &#x02212; 0.724 (&#x000b1;0.241) <bold><italic toggle="yes">MDCK</italic></bold> (n = 60, R<sup>2</sup> = 0.830, R<sup>2</sup><sub>adj.</sub> = 0.811, <break/>F = 43.11, <italic toggle="yes">p</italic> &#x0003c; 0.01, RMSECV = 0.329, RMSEP = 0.423, Q<sup>2</sup> = 0.779)<label>(15)</label></disp-formula></p><p>Equations (14) and (15) account for the reduced log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> of more lipophilic compounds and the effect of ionization at physiological pH; the negative influence of <bold><italic toggle="yes">PSA</italic></bold> on cornea permeability is similar to that encountered for transport across other biological barriers, e.g., the blood&#x02013;brain barrier [<xref rid="B59-pharmaceutics-17-00156" ref-type="bibr">59</xref>,<xref rid="B60-pharmaceutics-17-00156" ref-type="bibr">60</xref>] or skin [<xref rid="B61-pharmaceutics-17-00156" ref-type="bibr">61</xref>]. Caco-2 permeability is measured on human colon epithelial cancer cells and the permeability through a monolayer of caco-2 cells is a common predictor of human intestinal absorption [<xref rid="B62-pharmaceutics-17-00156" ref-type="bibr">62</xref>,<xref rid="B63-pharmaceutics-17-00156" ref-type="bibr">63</xref>]; MDCK (Madin&#x02212;Darby canine kidney) cells are also used to predict compounds&#x02019; membrane permeability [<xref rid="B64-pharmaceutics-17-00156" ref-type="bibr">64</xref>]. Both cell lines are also used to study other absorption phenomena, e.g., blood&#x02013;brain barrier permeability [<xref rid="B65-pharmaceutics-17-00156" ref-type="bibr">65</xref>]. MDCK and caco-2 cell lines share many common epithelial cell characteristics; for passively transported compounds, MDCK and caco-2 experimental permeabilities are highly correlated. However, due to overexpression of the P-gp system in the MDCK cells, the apparent permeability coefficients (log <bold><italic toggle="yes">P</italic></bold><sub>app</sub>) in both cell lines differ for compounds susceptible to P-gp-mediated active transport [<xref rid="B66-pharmaceutics-17-00156" ref-type="bibr">66</xref>].</p><p>The calculated MDCK and caco-2 permeabilities (descriptors <bold><italic toggle="yes">MDCK</italic></bold> and <bold><italic toggle="yes">Caco-2</italic></bold>) for compounds investigated in this study (training and test sets, <bold><italic toggle="yes"><underline>1</underline></italic></bold> to <bold><italic toggle="yes"><underline>69</underline></italic></bold>; 348 pesticides from different chemical families) are not correlated (R<sup>2</sup> = 0.189), so they could be incorporated into a single equation. In fact, considering the opposite signs of coefficients for both variables in Equation (15), it may be assumed that it is the difference between the caco-2 and MDCK permeabilities that is responsible for the slight improvement in the model&#x02019;s fit and accounts for ca. 3% of the total log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> variability, compared to the simplified Equation (16) (<xref rid="pharmaceutics-17-00156-f005" ref-type="fig">Figure 5</xref>).<disp-formula>log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> = &#x02212;4.542 (&#x000b1;0.141) + 0.220 (&#x000b1;0.042) log <bold><italic toggle="yes">D</italic></bold><sub>ACD</sub> + 0.375 (&#x000b1;0.079) <bold><italic toggle="yes">XLOGP3</italic></bold>
<break/>&#x02212; 0.0860 (&#x000b1;0.0231) (<bold><italic toggle="yes">XLOGP3</italic></bold>)<sup>2</sup> &#x02212; 0.0120 (0.0015) <bold><italic toggle="yes">TPSA</italic></bold> (n = 60, R<sup>2</sup> = 0.801, <break/>R<sup>2</sup><sub>adj.</sub> = 0.785, F = 54.87, <italic toggle="yes">p</italic> &#x0003c; 0.01, RMSECV = 0.336, RMSEP = 0.368, Q<sup>2</sup> = 0.762)<label>(16)</label></disp-formula></p><p>Equations (14)&#x02013;(16) give fairly similar results of predictions for the studied pesticides, but Equation (14) has the best statistical parameters, and for this reason, it was selected for further consideration. The compounds in the training and test sets are within the lipophilicity range <bold><italic toggle="yes">XLOGP3</italic></bold> ca. &#x02212;1 to 4. Based on similarities between different biological barriers, it was assumed that the applicability domain for Equation (14) covers the <bold><italic toggle="yes">XLOGP3</italic></bold> range ca. &#x02212;1 and 8; the log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> values across this lipophilicity range are between ca. &#x02212;6 and &#x02212;4. In the studied group of pesticides, there are only two compounds outside of these limits; their predicted log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> values are very low (&#x02212;10.01 for glyphosate and &#x02212;11.82 for paraquat, respectively). Such predicted values of log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> for glyphosate and paraquat imply that their cornea permeability is very low. In reality, it can be suspected that (similarly to, e.g., <bold><italic toggle="yes">BCF</italic></bold>) very highly hydrophilic or lipophilic compounds reach constant, low values of log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub>, but there is insufficient experimental data to determine these values and all predictions in this respect would be highly speculative.</p></sec><sec id="sec3dot2-pharmaceutics-17-00156"><title>3.2. Rules of Thumb for Ophthalmic Drugs (RO<sub>x</sub>)</title><p>As stated above, based on the analysis of 145 marketed ophthalmic drugs, it was determined that the optimum physico-chemical parameters known to facilitate drugs&#x02019; efficient topical ophthalmic delivery are determined by a set of simple rules going by the name of &#x0201c;RO<sub>x</sub>&#x0201d; [<xref rid="B14-pharmaceutics-17-00156" ref-type="bibr">14</xref>]:<list list-type="simple"><list-item><p>Rule #1: distribution coefficient at physiological pH clog <bold><italic toggle="yes">D</italic></bold><sub>pH7.4</sub> &#x0003c; 4.0.</p></list-item><list-item><p>Rule #2: topological polar surface area <bold><italic toggle="yes">TPSA</italic></bold> &#x0003c; 250 &#x000c5;<sup>2</sup>.</p></list-item><list-item><p>Rule #3: free energy of octanol&#x02013;water distribution &#x00394;<bold><italic toggle="yes">G</italic></bold><sub>o/w</sub> &#x0003c; 20 kJ/mol.</p></list-item><list-item><p>Rule #4: sufficient aqueous solubility <bold><italic toggle="yes">S</italic></bold> &#x0003e; 1 mM.</p></list-item></list></p><p>It was reported earlier that the majority of pesticides adhere to Lipinski&#x02019;s Ro5 [<xref rid="B14-pharmaceutics-17-00156" ref-type="bibr">14</xref>,<xref rid="B67-pharmaceutics-17-00156" ref-type="bibr">67</xref>,<xref rid="B68-pharmaceutics-17-00156" ref-type="bibr">68</xref>] and those pesticides that meet the requirements of the Ro5 are far more likely to cross the placenta than those that do not [<xref rid="B69-pharmaceutics-17-00156" ref-type="bibr">69</xref>]. With this in mind, we turned our attention to rules proposed for ophthalmic delivery (RO<sub>x</sub>); compounds <bold>1</bold> to <bold>90</bold> and 348 studied pesticides were analyzed in the context of these guidelines (as reported in the <xref rid="app1-pharmaceutics-17-00156" ref-type="app">Supplementary Materials</xref>) and the following was determined:<list list-type="bullet"><list-item><p>Compounds <bold>1</bold> to <bold>90</bold> fulfill Rules #1 to #3 (with one exception&#x02014;cinoxacin, <bold>53</bold>).</p></list-item><list-item><p>Pesticides fulfill Rule #2 without exception.</p></list-item><list-item><p>There are three highly hydrophilic pesticides (from the &#x0201c;miscellaneous&#x0201d; group: glyphosate, paraquat and schradan) that do not fulfill Rule #3.</p></list-item><list-item><p>There are several pesticides that breach Rule #1, but the percentage of such cases varies among the chemical families (carbamates&#x02014;15%; organochlorines&#x02014;83%; organophosphorus compounds&#x02014;29%; pyrethroids&#x02014;93%; triazines&#x02014;3%; miscellaneous&#x02014;40%).</p></list-item><list-item><p>A large proportion of compounds (both pesticides and drugs from the training/test sets) violate Rule #4. This violation, however, seems to be a minor issue compared to violations of Rules #1 to #3; according to Karami et al. [<xref rid="B14-pharmaceutics-17-00156" ref-type="bibr">14</xref>], the solubility range for ophthalmic drugs is relatively broad, with the lower limit of ca. 1 &#x000b5;M.</p></list-item><list-item><p>There are pesticides whose calculated aqueous solubility is below 1 &#x000b5;M. Such a low solubility is usually associated with high lipophilicity. Such compounds, which in fact violate two RO<sub>x</sub> rules, are expected to cross the cornea with difficulty, but their predicted log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> is sufficient to facilitate some trans-corneal transport.</p></list-item></list></p><p>RO<sub>x</sub> rules are crude filters generated on the basis of properties of existing ophthalmic drugs, and similarly to Lipinski&#x02019;s Ro5 [<xref rid="B67-pharmaceutics-17-00156" ref-type="bibr">67</xref>,<xref rid="B68-pharmaceutics-17-00156" ref-type="bibr">68</xref>], they seem to give many false-negative results, especially if they are taken too strictly. However, Karami et al. [<xref rid="B14-pharmaceutics-17-00156" ref-type="bibr">14</xref>] suggested that (considering how many deviations from their rules they observed) the violations of RO<sub>x</sub> should be treated as &#x0201c;warnings&#x0201d;; the ideal drug candidates for ophthalmic delivery should adhere to the RO<sub>x</sub> guidelines but compounds that do not may still exhibit some degree of corneal permeability, sufficient to be active inside the eyeball.</p></sec><sec id="sec3dot3-pharmaceutics-17-00156"><title>3.3. Pesticides&#x02019; Eye-Corrosive Potential</title><p>Although levels of the predicted cornea permeability for many pesticides appear to be very low, we knew that some of these compounds, although not entering the eye very easily, may still be dangerous for human and/or animal vision. Toxic effects of pesticides on the eyes in humans are mainly external, resulting from direct ocular exposure, but cases of ocular damage caused by systemic exposure have also been reported [<xref rid="B44-pharmaceutics-17-00156" ref-type="bibr">44</xref>]. Qualitative (high/low irritation or corrosion potential) or quantitative (scoring from the Draize Eye Irritation Test [<xref rid="B70-pharmaceutics-17-00156" ref-type="bibr">70</xref>]) indices of eye damage by chemicals are measured in vivo, ex vivo [<xref rid="B71-pharmaceutics-17-00156" ref-type="bibr">71</xref>] or in vitro [<xref rid="B72-pharmaceutics-17-00156" ref-type="bibr">72</xref>,<xref rid="B73-pharmaceutics-17-00156" ref-type="bibr">73</xref>]. In silico predictions of chemicals&#x02019; eye irritation or corrosion potential involve principal component analysis or different machine learning algorithms, e.g., support vector machines or Bayesian neural networks [<xref rid="B45-pharmaceutics-17-00156" ref-type="bibr">45</xref>,<xref rid="B71-pharmaceutics-17-00156" ref-type="bibr">71</xref>,<xref rid="B74-pharmaceutics-17-00156" ref-type="bibr">74</xref>,<xref rid="B75-pharmaceutics-17-00156" ref-type="bibr">75</xref>,<xref rid="B76-pharmaceutics-17-00156" ref-type="bibr">76</xref>,<xref rid="B77-pharmaceutics-17-00156" ref-type="bibr">77</xref>,<xref rid="B78-pharmaceutics-17-00156" ref-type="bibr">78</xref>,<xref rid="B79-pharmaceutics-17-00156" ref-type="bibr">79</xref>,<xref rid="B80-pharmaceutics-17-00156" ref-type="bibr">80</xref>,<xref rid="B81-pharmaceutics-17-00156" ref-type="bibr">81</xref>,<xref rid="B82-pharmaceutics-17-00156" ref-type="bibr">82</xref>,<xref rid="B83-pharmaceutics-17-00156" ref-type="bibr">83</xref>]. In vitro and in silico models are important in the field of eye toxicity testing, as they are likely to substitute in vivo animal studies to some degree, thus contributing to the elimination of methods that are undesirable in the context of animal welfare.</p><p>In this study, we evaluated the corrosive potential of the studied pesticides using novel artificial neural network (ANN) binary (Yes&#x02014;1; No&#x02014;0) models of eye corrosion based on a large dataset collected by Wang et al. (2299 compounds) [<xref rid="B45-pharmaceutics-17-00156" ref-type="bibr">45</xref>]. The ANN models we propose are based on a set of straightforward, self-explaining descriptors (listed in order of decreasing importance, based on Global Sensitivity Analysis scores &#x0003e; 1): <bold><italic toggle="yes">MW</italic></bold>, <bold><italic toggle="yes">PSA</italic></bold>, <bold><italic toggle="yes">NH</italic></bold>, <bold><italic toggle="yes">O</italic></bold>, <bold><italic toggle="yes">N</italic></bold>, <bold><italic toggle="yes">DONORS</italic></bold>, <bold><italic toggle="yes">ALogPS_logP</italic></bold>, <bold><italic toggle="yes">ALogPS_logS</italic></bold>, <bold><italic toggle="yes">ACCEPTORS</italic></bold>, <bold><italic toggle="yes">HALOG</italic></bold>, <bold><italic toggle="yes">P</italic></bold> and <bold><italic toggle="yes">S</italic></bold>. The ANNs of different architectures (presented in <xref rid="app1-pharmaceutics-17-00156" ref-type="app">Supplementary Materials</xref>) obtained at this stage of the study predict ca. 96% of cases correctly (in the training, test and validation groups), with almost equal percentages of false-negative and false-positive predictions (ca. 4%) (<xref rid="pharmaceutics-17-00156-t001" ref-type="table">Table 1</xref>). Applied to the new compounds (348 pesticides), the networks return the expected &#x0201c;1&#x0201d; (or &#x0201c;Yes&#x0201d;) result, e.g., for glyphosate and paraquat, whose cornea-damaging activity is known [<xref rid="B44-pharmaceutics-17-00156" ref-type="bibr">44</xref>].</p></sec></sec><sec sec-type="conclusions" id="sec4-pharmaceutics-17-00156"><title>4. Conclusions</title><p>A total of 348 pesticides were investigated in the context of their ability to cross the cornea, using novel in silico models based on a set of compounds whose experimental permeability coefficients are known. It was established that the physico-chemical properties of a large number of studied pesticides are outside the ranges typical of drugs used to train and test models. Extrapolation of linear models to predict the cornea permeability of highly lipophilic compounds (e.g., pesticides from the families of pyrethroids and organochlorines) leads to suspiciously high permeability values, implying very easy transport across the cornea. It was assumed, by analogy to other absorption/transport phenomena (e.g., bioconcentration in aquatic organisms), that the relationship between cornea permeability and lipophilicity is likely to be non-linear. The core of our improved models, accounting for the decrease in cornea permeability of highly lipophilic pesticides (log <bold><italic toggle="yes">P</italic></bold> up to ca. 8), involves (i) a quadratic function of lipophilicity (<bold><italic toggle="yes">XLOGP3</italic></bold>)<sup>2</sup>, (ii) the octanol&#x02013;water distribution coefficient log <bold><italic toggle="yes">D</italic></bold> at pH 7.4 to account for compounds&#x02019; ionization in physiological conditions; and (iii) polar surface area (this parameter, according to Karami, should not exceed a certain limit for compounds absorbed across the cornea, e.g., ophthalmic drugs [<xref rid="B14-pharmaceutics-17-00156" ref-type="bibr">14</xref>]).</p><p>Regarding the initial question&#x02014;&#x0201c;How serious is the problem of pesticides&#x02019; cornea permeability?&#x0201d;&#x02014;we have concluded (based on our predictions and the rules of thumb proposed by Karami [<xref rid="B14-pharmaceutics-17-00156" ref-type="bibr">14</xref>]) that the majority of studied pesticides are likely to cross the cornea, but this process seems to be limited for many compounds, especially from the chemical families of organochlorines or pyrethroids. In the case of almost all the pesticides, however, if they come into direct contact with the eye surface as liquids, aerosols or vapors, there is a risk of ocular surface damage which can trigger a range of symptoms such as itching, hyperemia, photophobia or blurred vision. In more severe cases (especially after prolonged contact), the effects may include the development of dry eye disease, corneal ulcers, cataracts, glaucoma and impaired vision [<xref rid="B43-pharmaceutics-17-00156" ref-type="bibr">43</xref>]. Theoretical predictions of eye corrosion potential (EC) of the studied pesticides (<xref rid="app1-pharmaceutics-17-00156" ref-type="app">Supplementary Materials</xref>) based on artificial neural network models (built upon a large group of diverse compounds whose experimental potential to cause eye corrosion is known) show that eye-corrosive cases are especially abundant among the pesticides from organochlorine and organophosphorus families. The requirements regarding labeling and safety precautions for pesticides vary according to the region. Many such compounds are (or should be) labeled as &#x0201c;causing serious eye damage&#x0201d;, &#x0201c;causing eye irritation&#x0201d; or &#x0201c;causing serious eye irritation&#x0201d; (H318, H320 or H319 health phrases according to [<xref rid="B84-pharmaceutics-17-00156" ref-type="bibr">84</xref>]). In many countries (e.g., in Poland), they can only be sold and used by authorized persons who have completed special courses and can provide the participants with proper understanding of pesticides&#x02019; safety, application techniques and regulatory compliance.</p><p>Some pesticides (e.g., paraquat or glyphosate) are known to be toxic to the ocular surface [<xref rid="B44-pharmaceutics-17-00156" ref-type="bibr">44</xref>]; for others, their impact on ocular health is just being discovered. Extreme caution and the use of eye protection must be recommended to avoid contact with the ocular surface, and further studies on the effects of such contacts are underway.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-pharmaceutics-17-00156"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at <uri xlink:href="https://www.mdpi.com/article/10.3390/pharmaceutics17020156/s1">https://www.mdpi.com/article/10.3390/pharmaceutics17020156/s1</uri>.</p><supplementary-material id="pharmaceutics-17-00156-s001" position="float" content-type="local-data"><media xlink:href="pharmaceutics-17-00156-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, A.W.S. and A.M.S.; methodology, A.W.S.; validation, A.W.S.; investigation, A.W.S., K.W. and A.M.S.; writing&#x02014;original draft preparation, A.W.S. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Data reported in the manuscript.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><glossary><title>Abbreviations</title><array><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">SsNH2</italic>
</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">atom type e-state descriptors, number of ssNH2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">SaaCH</italic>
</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">atom type e-state descriptors, sum of aaCH</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Se1C1C3a</italic>
</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">single bond-type e-state index</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Se1C3O1d</italic>
</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">single bond-type e-state index</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><bold><italic toggle="yes">NH</italic></bold>, <italic toggle="yes"><bold>O</bold></italic>, <italic toggle="yes"><bold>N</bold></italic>, <italic toggle="yes"><bold>DONORS</bold></italic>, <italic toggle="yes"><bold>ACCEPTORS</bold></italic>, <italic toggle="yes"><bold>HALOG</bold></italic>, <italic toggle="yes"><bold>P</bold></italic> and <italic toggle="yes"><bold>S</bold></italic></td><td align="left" valign="middle" rowspan="1" colspan="1">counts of particular atoms</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">ALogPS_logS</italic>
</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">aqueous solubility</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
log <bold><italic toggle="yes">D</italic></bold><sub>ACD</sub></td><td align="left" valign="middle" rowspan="1" colspan="1">octanol&#x02013;water distribution coefficients at pH = 7.4</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><bold><italic toggle="yes">ALogPS_logP</italic></bold>; log <italic toggle="yes"><bold>P</bold></italic><sub>ACD</sub>; <italic toggle="yes"><bold>XLOGP3</bold></italic>; <italic toggle="yes"><bold>iLOGP</bold></italic>; <italic toggle="yes"><bold>MLOGP</bold></italic>; <italic toggle="yes"><bold>WLOGP</bold></italic>; <italic toggle="yes"><bold>Silicos-IT Log P</bold></italic>;
<bold><italic toggle="yes">Consensus Log P</italic></bold></td><td align="left" valign="middle" rowspan="1" colspan="1">octanol&#x02013;water partition coefficients calculated according to different algorithms</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">MW</italic>
</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">molecular weight</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Vol</italic>
</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">van der Waals volume</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">nHD</italic>
</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">H-bond donor count (OH + NH)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">nHA</italic>
</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">H-bond acceptor count (N + O)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">fChar</italic>
</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">formal charge</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">nRig</italic>
</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">rigid (non-flexible) bond count</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">nRot</italic>
</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">rotatable bond count</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Flex</italic>
</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">flexibility = <bold><italic toggle="yes">nRot/nRig</italic></bold></td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">nStereo</italic>
</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">stereocenter count</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">MaxRing</italic>
</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">maximum ring size</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">nHet</italic>
</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">number of heteroatoms, i.e., non-carbon atoms including hydrogens</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">F<sub>Csp3</sub></italic>
</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">fraction of sp<sup>3</sup> carbons</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">PSA</italic>
</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">polar surface area</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">TPSA</italic>
</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">topological surface area</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">PAMPA</italic>
</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">parallel artificial membrane permeability assay</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">MDCK</italic>
</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">Madin&#x02212;Darby canine kidney cells&#x02019; logarithmic permeability coefficient</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">Caco-2</italic>
</bold>
</td><td align="left" valign="middle" rowspan="1" colspan="1">human colon adenocarcinoma cell lines&#x02019; permeability</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">RMSEP</td><td align="left" valign="middle" rowspan="1" colspan="1">root mean square error of prediction (external test set)</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">RMSECV</td><td align="left" valign="middle" rowspan="1" colspan="1">root mean square error of cross-validation</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Q<sup>2</sup></td><td align="left" valign="middle" rowspan="1" colspan="1">leave-one-out cross-validated R<sup>2</sup></td></tr></tbody></array></glossary><ref-list><title>References</title><ref id="B1-pharmaceutics-17-00156"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ghorbanzad&#x02019;E</surname><given-names>M.</given-names></name>
<name><surname>Fatemi</surname><given-names>M.H.</given-names></name>
<name><surname>Karimpour</surname><given-names>M.</given-names></name>
<name><surname>Andersson</surname><given-names>P.L.</given-names></name>
</person-group><article-title>Quantitative and Qualitative Prediction of Corneal Permeability for Drug-like Compounds</article-title><source>Talanta</source><year>2011</year><volume>85</volume><fpage>2686</fpage><lpage>2694</lpage><pub-id pub-id-type="doi">10.1016/j.talanta.2011.08.060</pub-id><pub-id pub-id-type="pmid">21962703</pub-id>
</element-citation></ref><ref id="B2-pharmaceutics-17-00156"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Edwards</surname><given-names>A.</given-names></name>
<name><surname>Prausnitz</surname><given-names>M.R.</given-names></name>
</person-group><article-title>Predicted Permeability of the Cornea to Topical Drugs</article-title><source>Pharm. Res.</source><year>2001</year><volume>18</volume><fpage>1497</fpage><lpage>1508</lpage><pub-id pub-id-type="doi">10.1023/A:1013061926851</pub-id><pub-id pub-id-type="pmid">11758755</pub-id>
</element-citation></ref><ref id="B3-pharmaceutics-17-00156"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mun</surname><given-names>E.A.</given-names></name>
<name><surname>Morrison</surname><given-names>P.W.J.</given-names></name>
<name><surname>Williams</surname><given-names>A.C.</given-names></name>
<name><surname>Khutoryanskiy</surname><given-names>V.V.</given-names></name>
</person-group><article-title>On the Barrier Properties of the Cornea: A Microscopy Study of the Penetration of Fluorescently Labeled Nanoparticles, Polymers, and Sodium Fluorescein</article-title><source>Mol. Pharm.</source><year>2014</year><volume>11</volume><fpage>3556</fpage><lpage>3564</lpage><pub-id pub-id-type="doi">10.1021/mp500332m</pub-id><pub-id pub-id-type="pmid">25165886</pub-id>
</element-citation></ref><ref id="B4-pharmaceutics-17-00156"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ambati</surname><given-names>J.</given-names></name>
<name><surname>Canakis</surname><given-names>C.S.</given-names></name>
<name><surname>Miller</surname><given-names>J.W.</given-names></name>
<name><surname>Gragoudas</surname><given-names>E.S.</given-names></name>
<name><surname>Edwards</surname><given-names>A.</given-names></name>
<name><surname>Weissgold</surname><given-names>D.J.</given-names></name>
<name><surname>Kim</surname><given-names>I.</given-names></name>
<name><surname>Delori</surname><given-names>F.C.</given-names></name>
<name><surname>Adamis</surname><given-names>A.P.</given-names></name>
</person-group><article-title>Diffusion of High Molecular Weight Compounds Through Sclera</article-title><source>Investig. Ophthalmol. Vis. Sci.</source><year>2000</year><volume>41</volume><fpage>1181</fpage><lpage>1185</lpage><pub-id pub-id-type="pmid">10752958</pub-id>
</element-citation></ref><ref id="B5-pharmaceutics-17-00156"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Waite</surname><given-names>D.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Jones</surname><given-names>D.</given-names></name>
<name><surname>Stitt</surname><given-names>A.</given-names></name>
<name><surname>Raj Singh</surname><given-names>T.R.</given-names></name>
</person-group><article-title>Posterior Drug Delivery via Periocular Route: Challenges and Opportunities</article-title><source>Ther. Deliv.</source><year>2017</year><volume>8</volume><fpage>685</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.4155/tde-2017-0097</pub-id><pub-id pub-id-type="pmid">28730942</pub-id>
</element-citation></ref><ref id="B6-pharmaceutics-17-00156"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Prausnitz</surname><given-names>M.R.</given-names></name>
</person-group><article-title>Permeability of Cornea, Sciera, and Conjunctiva: A Literature Analysis for Drug Delivery to the Eye</article-title><source>J. Pharm. Sci.</source><year>1998</year><volume>87</volume><fpage>1479</fpage><lpage>1488</lpage><pub-id pub-id-type="doi">10.1021/js9802594</pub-id><pub-id pub-id-type="pmid">10189253</pub-id>
</element-citation></ref><ref id="B7-pharmaceutics-17-00156"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mosher</surname><given-names>G.L.</given-names></name>
<name><surname>Mikkelson</surname><given-names>T.J.</given-names></name>
</person-group><article-title>Permeability of the N-Alkyl p-Aminobenzoate Esters across the Isolated Corneal Membrane of the Rabbit</article-title><source>Int. J. Pharm.</source><year>1979</year><volume>2</volume><fpage>239</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1016/0378-5173(79)90023-1</pub-id></element-citation></ref><ref id="B8-pharmaceutics-17-00156"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schoenwald</surname><given-names>R.D.</given-names></name>
<name><surname>Ward</surname><given-names>R.L.</given-names></name>
</person-group><article-title>Relationship between Steroid Permeability across Excised Rabbit Cornea and Octanol-water Partition Coefficients</article-title><source>J. Pharm. Sci.</source><year>1978</year><volume>67</volume><fpage>786</fpage><lpage>788</lpage><pub-id pub-id-type="doi">10.1002/jps.2600670614</pub-id><pub-id pub-id-type="pmid">660456</pub-id>
</element-citation></ref><ref id="B9-pharmaceutics-17-00156"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schoenwald</surname><given-names>R.D.</given-names></name>
<name><surname>Huang</surname><given-names>H.-S.</given-names></name>
</person-group><article-title>Corneal Penetration Behavior of &#x00392;-blocking Agents I: Physicochemical Factors</article-title><source>J. Pharm. Sci.</source><year>1983</year><volume>72</volume><fpage>1266</fpage><lpage>1272</lpage><pub-id pub-id-type="doi">10.1002/jps.2600721108</pub-id><pub-id pub-id-type="pmid">6139471</pub-id>
</element-citation></ref><ref id="B10-pharmaceutics-17-00156"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>W.</given-names></name>
<name><surname>Sasaki</surname><given-names>H.</given-names></name>
<name><surname>Chien</surname><given-names>D.S.</given-names></name>
<name><surname>Lee</surname><given-names>V.H.L.</given-names></name>
</person-group><article-title>Lipophilicity Influence on Conjunctival Drug Penetration in the Pigmented Rabbit: A Comparison with Corneal Penetration</article-title><source>Curr. Eye Res.</source><year>1991</year><volume>10</volume><fpage>571</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.3109/02713689109001766</pub-id><pub-id pub-id-type="pmid">1680041</pub-id>
</element-citation></ref><ref id="B11-pharmaceutics-17-00156"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Santana</surname><given-names>C.P.</given-names></name>
<name><surname>Matter</surname><given-names>B.A.</given-names></name>
<name><surname>Patil</surname><given-names>M.A.</given-names></name>
<name><surname>Silva-Cunha</surname><given-names>A.</given-names></name>
<name><surname>Kompella</surname><given-names>U.B.</given-names></name>
</person-group><article-title>Corneal Permeability and Uptake of Twenty-Five Drugs: Species Comparison and Quantitative Structure&#x02013;Permeability Relationships</article-title><source>Pharmaceutics</source><year>2023</year><volume>15</volume><elocation-id>1646</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics15061646</pub-id><pub-id pub-id-type="pmid">37376094</pub-id>
</element-citation></ref><ref id="B12-pharmaceutics-17-00156"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Malhotra</surname><given-names>M.</given-names></name>
<name><surname>Majumdar</surname><given-names>D.K.</given-names></name>
</person-group><article-title>Permeation through Cornea</article-title><source>Indian J. Exp. Biol.</source><year>2001</year><volume>39</volume><fpage>11</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">11349520</pub-id>
</element-citation></ref><ref id="B13-pharmaceutics-17-00156"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>W.</given-names></name>
<name><surname>Prausnitz</surname><given-names>M.R.</given-names></name>
<name><surname>Edwards</surname><given-names>A.</given-names></name>
</person-group><article-title>Model of Transient Drug Diffusion across Cornea</article-title><source>J. Control. Release</source><year>2004</year><volume>99</volume><fpage>241</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1016/j.jconrel.2004.07.001</pub-id><pub-id pub-id-type="pmid">15380634</pub-id>
</element-citation></ref><ref id="B14-pharmaceutics-17-00156"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Karami</surname><given-names>T.K.</given-names></name>
<name><surname>Hailu</surname><given-names>S.</given-names></name>
<name><surname>Feng</surname><given-names>S.</given-names></name>
<name><surname>Graham</surname><given-names>R.</given-names></name>
<name><surname>Gukasyan</surname><given-names>H.J.</given-names></name>
</person-group><article-title>Eyes on Lipinski&#x02019;s Rule of Five: A New &#x0201c;Rule of Thumb&#x0201d; for Physicochemical Design Space of Ophthalmic Drugs</article-title><source>J. Ocul. Pharmacol. Ther.</source><year>2022</year><volume>38</volume><fpage>43</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1089/jop.2021.0069</pub-id><pub-id pub-id-type="pmid">34905402</pub-id>
</element-citation></ref><ref id="B15-pharmaceutics-17-00156"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Toffoletto</surname><given-names>N.</given-names></name>
<name><surname>Chauhan</surname><given-names>A.</given-names></name>
<name><surname>Alvarez-Lorenzo</surname><given-names>C.</given-names></name>
<name><surname>Saramago</surname><given-names>B.</given-names></name>
<name><surname>Serro</surname><given-names>A.P.</given-names></name>
</person-group><article-title>Asymmetry in Drug Permeability through the Cornea</article-title><source>Pharmaceutics</source><year>2021</year><volume>13</volume><elocation-id>694</elocation-id><pub-id pub-id-type="doi">10.3390/pharmaceutics13050694</pub-id><pub-id pub-id-type="pmid">34064834</pub-id>
</element-citation></ref><ref id="B16-pharmaceutics-17-00156"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cunha-Vaz</surname><given-names>J.</given-names></name>
<name><surname>Bernardes</surname><given-names>R.</given-names></name>
<name><surname>Lobo</surname><given-names>C.</given-names></name>
</person-group><article-title>Blood-Retinal Barrier</article-title><source>Eur. J. Ophthalmol.</source><year>2011</year><volume>21</volume><fpage>3</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.5301/EJO.2010.6049</pub-id><pub-id pub-id-type="pmid">23264323</pub-id>
</element-citation></ref><ref id="B17-pharmaceutics-17-00156"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>del Amo</surname><given-names>E.M.</given-names></name>
<name><surname>Rimpel&#x000e4;</surname><given-names>A.K.</given-names></name>
<name><surname>Heikkinen</surname><given-names>E.</given-names></name>
<name><surname>Kari</surname><given-names>O.K.</given-names></name>
<name><surname>Ramsay</surname><given-names>E.</given-names></name>
<name><surname>Lajunen</surname><given-names>T.</given-names></name>
<name><surname>Schmitt</surname><given-names>M.</given-names></name>
<name><surname>Pelkonen</surname><given-names>L.</given-names></name>
<name><surname>Bhattacharya</surname><given-names>M.</given-names></name>
<name><surname>Richardson</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>Pharmacokinetic Aspects of Retinal Drug Delivery</article-title><source>Prog. Retin. Eye Res.</source><year>2017</year><volume>57</volume><fpage>134</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/j.preteyeres.2016.12.001</pub-id><pub-id pub-id-type="pmid">28028001</pub-id>
</element-citation></ref><ref id="B18-pharmaceutics-17-00156"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grass</surname><given-names>G.M.</given-names></name>
<name><surname>Robinson</surname><given-names>J.R.</given-names></name>
</person-group><article-title>Mechanisms of Corneal Drug Penetration I: In Vivo and In Vitro Kinetics</article-title><source>J. Pharm. Sci.</source><year>1988</year><volume>77</volume><fpage>3</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1002/jps.2600770103</pub-id><pub-id pub-id-type="pmid">3126290</pub-id>
</element-citation></ref><ref id="B19-pharmaceutics-17-00156"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Agarwal</surname><given-names>P.</given-names></name>
<name><surname>Rupenthal</surname><given-names>I.D.</given-names></name>
</person-group><article-title>In Vitro and Ex Vivo Corneal Penetration and Absorption Models</article-title><source>Drug Deliv. Transl. Res.</source><year>2016</year><volume>6</volume><fpage>634</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1007/s13346-015-0275-6</pub-id><pub-id pub-id-type="pmid">26762419</pub-id>
</element-citation></ref><ref id="B20-pharmaceutics-17-00156"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>De Hoon</surname><given-names>I.</given-names></name>
<name><surname>Boukherroub</surname><given-names>R.</given-names></name>
<name><surname>De Smedt</surname><given-names>S.C.</given-names></name>
<name><surname>Szunerits</surname><given-names>S.</given-names></name>
<name><surname>Sauvage</surname><given-names>F.</given-names></name>
</person-group><article-title>In Vitro and Ex Vivo Models for Assessing Drug Permeation across the Cornea</article-title><source>Mol. Pharm.</source><year>2023</year><volume>20</volume><fpage>3298</fpage><lpage>3319</lpage><pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.3c00195</pub-id><pub-id pub-id-type="pmid">37314950</pub-id>
</element-citation></ref><ref id="B21-pharmaceutics-17-00156"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Begum</surname><given-names>G.</given-names></name>
<name><surname>Leigh</surname><given-names>T.</given-names></name>
<name><surname>Courtie</surname><given-names>E.</given-names></name>
<name><surname>Moakes</surname><given-names>R.</given-names></name>
<name><surname>Butt</surname><given-names>G.</given-names></name>
<name><surname>Ahmed</surname><given-names>Z.</given-names></name>
<name><surname>Rauz</surname><given-names>S.</given-names></name>
<name><surname>Logan</surname><given-names>A.</given-names></name>
<name><surname>Blanch</surname><given-names>R.J.</given-names></name>
</person-group><article-title>Rapid Assessment of Ocular Drug Delivery in a Novel Ex Vivo Corneal Model</article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><elocation-id>11754</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-020-68254-1</pub-id><pub-id pub-id-type="pmid">32678110</pub-id>
</element-citation></ref><ref id="B22-pharmaceutics-17-00156"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pescina</surname><given-names>S.</given-names></name>
<name><surname>Govoni</surname><given-names>P.</given-names></name>
<name><surname>Potenza</surname><given-names>A.</given-names></name>
<name><surname>Padula</surname><given-names>C.</given-names></name>
<name><surname>Santi</surname><given-names>P.</given-names></name>
<name><surname>Nicoli</surname><given-names>S.</given-names></name>
</person-group><article-title>Development of a Convenient Ex Vivo Model for the Study of the Transcorneal Permeation of Drugs: Histological and Permeability Evaluation</article-title><source>J. Pharm. Sci.</source><year>2015</year><volume>104</volume><fpage>63</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1002/jps.24231</pub-id><pub-id pub-id-type="pmid">25394188</pub-id>
</element-citation></ref><ref id="B23-pharmaceutics-17-00156"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maren</surname><given-names>T.H.</given-names></name>
<name><surname>Jankowska</surname><given-names>L.</given-names></name>
<name><surname>Sanyal</surname><given-names>G.</given-names></name>
<name><surname>Edelhauser</surname><given-names>H.F.</given-names></name>
</person-group><article-title>The Transcorneal Permeability of Sulfonamide Carbonic Anhydrase Inhibitors and Their Effect on Aqueous Humor Secretion</article-title><source>Exp. Eye Res.</source><year>1983</year><volume>36</volume><fpage>457</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1016/0014-4835(83)90041-6</pub-id><pub-id pub-id-type="pmid">6852128</pub-id>
</element-citation></ref><ref id="B24-pharmaceutics-17-00156"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reichl</surname><given-names>S.</given-names></name>
<name><surname>K&#x000f6;lln</surname><given-names>C.</given-names></name>
<name><surname>Hahne</surname><given-names>M.</given-names></name>
<name><surname>Verstraelen</surname><given-names>J.</given-names></name>
</person-group><article-title>In Vitro Cell Culture Models to Study the Corneal Drug Absorption</article-title><source>Expert Opin. Drug Metab. Toxicol.</source><year>2011</year><volume>7</volume><fpage>559</fpage><lpage>578</lpage><pub-id pub-id-type="doi">10.1517/17425255.2011.562195</pub-id><pub-id pub-id-type="pmid">21381983</pub-id>
</element-citation></ref><ref id="B25-pharmaceutics-17-00156"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Siran</surname><given-names>W.</given-names></name>
<name><surname>Ghezzi</surname><given-names>C.E.</given-names></name>
<name><surname>Cairns</surname><given-names>D.M.</given-names></name>
<name><surname>Pollard</surname><given-names>R.E.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Gomes</surname><given-names>R.</given-names></name>
<name><surname>McKay</surname><given-names>T.B.</given-names></name>
<name><surname>Pouli</surname><given-names>D.</given-names></name>
<name><surname>Jamali</surname><given-names>A.</given-names></name>
<name><surname>Georgakoudi</surname><given-names>I.</given-names></name>
<etal/>
</person-group><article-title>Human Corneal Tissue Model for Nociceptive Assessments</article-title><source>Adv. Health Mater.</source><year>2018</year><volume>7</volume><fpage>1800488</fpage><pub-id pub-id-type="doi">10.1002/adhm.201800488</pub-id></element-citation></ref><ref id="B26-pharmaceutics-17-00156"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Toropainen</surname><given-names>E.</given-names></name>
<name><surname>Ranta</surname><given-names>V.P.</given-names></name>
<name><surname>Talvitie</surname><given-names>A.</given-names></name>
<name><surname>Suhonen</surname><given-names>P.</given-names></name>
<name><surname>Urtti</surname><given-names>A.</given-names></name>
</person-group><article-title>Culture Model of Human Corneal Epithelium for Prediction of Ocular Drug Absorption</article-title><source>Investig. Ophthalmol. Vis. Sci.</source><year>2001</year><volume>42</volume><fpage>2942</fpage><lpage>2948</lpage><pub-id pub-id-type="pmid">11687540</pub-id>
</element-citation></ref><ref id="B27-pharmaceutics-17-00156"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chac&#x000f3;n</surname><given-names>M.</given-names></name>
<name><surname>V&#x000e1;zquez</surname><given-names>N.</given-names></name>
<name><surname>Berisa</surname><given-names>S.</given-names></name>
<name><surname>Persinal</surname><given-names>M.</given-names></name>
<name><surname>S&#x000e1;nchez</surname><given-names>M.</given-names></name>
<name><surname>Baamonde</surname><given-names>B.</given-names></name>
<name><surname>Alfonso</surname><given-names>J.F.</given-names></name>
<name><surname>Cueto</surname><given-names>L.F.V.</given-names></name>
<name><surname>Merayo-Lloves</surname><given-names>J.</given-names></name>
<name><surname>Meana</surname><given-names>A.</given-names></name>
</person-group><article-title>QobuR&#x02014;A New in Vitro Human Corneal Epithelial Model for Preclinical Drug Screening</article-title><source>Eur. J. Pharm. Biopharm.</source><year>2019</year><volume>136</volume><fpage>164</fpage><lpage>173</lpage><pub-id pub-id-type="doi">10.1016/j.ejpb.2019.01.023</pub-id><pub-id pub-id-type="pmid">30690064</pub-id>
</element-citation></ref><ref id="B28-pharmaceutics-17-00156"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abdalkader</surname><given-names>R.K.</given-names></name>
<name><surname>Fujita</surname><given-names>T.</given-names></name>
</person-group><article-title>Corneal Epithelium Models for Safety Assessment in Drug Development: Present and Future Directions</article-title><source>Exp. Eye Res.</source><year>2023</year><volume>237</volume><fpage>109697</fpage><pub-id pub-id-type="doi">10.1016/j.exer.2023.109697</pub-id><pub-id pub-id-type="pmid">37890755</pub-id>
</element-citation></ref><ref id="B29-pharmaceutics-17-00156"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vincze</surname><given-names>A.</given-names></name>
<name><surname>Darg&#x000f3;</surname><given-names>G.</given-names></name>
<name><surname>R&#x000e1;cz</surname><given-names>A.</given-names></name>
<name><surname>Balogh</surname><given-names>G.T.</given-names></name>
</person-group><article-title>A Corneal-PAMPA-Based in Silico Model for Predicting Corneal Permeability</article-title><source>J. Pharm. Biomed. Anal.</source><year>2021</year><volume>203</volume><elocation-id>114218</elocation-id><pub-id pub-id-type="doi">10.1016/j.jpba.2021.114218</pub-id><pub-id pub-id-type="pmid">34166924</pub-id>
</element-citation></ref><ref id="B30-pharmaceutics-17-00156"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dobri&#x0010d;i&#x00107;</surname><given-names>V.</given-names></name>
<name><surname>Nikolic</surname><given-names>K.</given-names></name>
<name><surname>Vladimirov</surname><given-names>S.</given-names></name>
<name><surname>&#x0010c;udina</surname><given-names>O.</given-names></name>
</person-group><article-title>Biopartitioning Micellar Chromatography as a Predictive Tool for Skin and Corneal Permeability of Newly Synthesized 17&#x003b2;-Carboxamide Steroids</article-title><source>Eur. J. Pharm. Sci.</source><year>2014</year><volume>56</volume><fpage>105</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1016/j.ejps.2014.02.007</pub-id><pub-id pub-id-type="pmid">24607748</pub-id>
</element-citation></ref><ref id="B31-pharmaceutics-17-00156"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mart&#x000ed;n-Biosca</surname><given-names>Y.</given-names></name>
<name><surname>Molero-Monfort</surname><given-names>M.</given-names></name>
<name><surname>Sagrado</surname><given-names>S.</given-names></name>
<name><surname>Villanueva-Cama&#x000f1;as</surname><given-names>R.M.</given-names></name>
<name><surname>Medina-Hern&#x000e1;ndez</surname><given-names>M.J.</given-names></name>
</person-group><article-title>Rapid in Vitro Test to Predict Ocular Tissue Permeability Based on Biopartitioning Micellar Chromatography</article-title><source>Eur. J. Pharm. Sci.</source><year>2003</year><volume>20</volume><fpage>209</fpage><lpage>216</lpage><pub-id pub-id-type="doi">10.1016/S0928-0987(03)00195-7</pub-id><pub-id pub-id-type="pmid">14550887</pub-id>
</element-citation></ref><ref id="B32-pharmaceutics-17-00156"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>C.</given-names></name>
<name><surname>Yang</surname><given-names>J.</given-names></name>
</person-group><article-title>MI-QSAR Models for Prediction of Corneal Permeability of Organic Compounds</article-title><source>Acta Pharmacol. Sin.</source><year>2006</year><volume>27</volume><fpage>193</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1111/j.1745-7254.2006.00241.x</pub-id><pub-id pub-id-type="pmid">16412269</pub-id>
</element-citation></ref><ref id="B33-pharmaceutics-17-00156"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sharma</surname><given-names>C.</given-names></name>
<name><surname>Velpandian</surname><given-names>T.</given-names></name>
<name><surname>Biswas</surname><given-names>N.R.</given-names></name>
<name><surname>Nayak</surname><given-names>N.</given-names></name>
<name><surname>Vajpayee</surname><given-names>R.B.</given-names></name>
<name><surname>Ghose</surname><given-names>S.</given-names></name>
</person-group><article-title>Development of Novel In Silico Model to Predict Corneal Permeability for Congeneric Drugs: A QSPR Approach</article-title><source>J. Biomed. Biotechnol.</source><year>2011</year><volume>2011</volume><elocation-id>483869</elocation-id><pub-id pub-id-type="doi">10.1155/2011/483869</pub-id><pub-id pub-id-type="pmid">21403901</pub-id>
</element-citation></ref><ref id="B34-pharmaceutics-17-00156"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zivkovic</surname><given-names>M.</given-names></name>
<name><surname>Zlatanovic</surname><given-names>M.</given-names></name>
<name><surname>Zlatanovic</surname><given-names>N.</given-names></name>
<name><surname>Golubovic</surname><given-names>M.</given-names></name>
<name><surname>Veselinovic&#x02019;</surname><given-names>A.M.</given-names></name>
</person-group><article-title>A QSAR Model for Predicting the Corneal Permeability of Drugs&#x02014;The Application of the Monte Carlo Optimization Method</article-title><source>New J. Chem.</source><year>2023</year><volume>47</volume><fpage>224</fpage><pub-id pub-id-type="doi">10.1039/D2NJ04301G</pub-id></element-citation></ref><ref id="B35-pharmaceutics-17-00156"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pak</surname><given-names>J.</given-names></name>
<name><surname>Chen</surname><given-names>Z.J.</given-names></name>
<name><surname>Sun</surname><given-names>K.</given-names></name>
<name><surname>Przekwas</surname><given-names>A.</given-names></name>
<name><surname>Walenga</surname><given-names>R.</given-names></name>
<name><surname>Fan</surname><given-names>J.H.</given-names></name>
</person-group><article-title>Computational Modeling of Drug Transport across the in Vitro Cornea</article-title><source>Comput. Biol. Med.</source><year>2018</year><volume>92</volume><fpage>139</fpage><lpage>146</lpage><pub-id pub-id-type="doi">10.1016/j.compbiomed.2017.11.009</pub-id><pub-id pub-id-type="pmid">29175100</pub-id>
</element-citation></ref><ref id="B36-pharmaceutics-17-00156"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ramsay</surname><given-names>E.</given-names></name>
<name><surname>del Amo</surname><given-names>E.M.</given-names></name>
<name><surname>Toropainen</surname><given-names>E.</given-names></name>
<name><surname>Tengvall-Unadike</surname><given-names>U.</given-names></name>
<name><surname>Ranta</surname><given-names>V.P.</given-names></name>
<name><surname>Urtti</surname><given-names>A.</given-names></name>
<name><surname>Ruponen</surname><given-names>M.</given-names></name>
</person-group><article-title>Corneal and Conjunctival Drug Permeability: Systematic Comparison and Pharmacokinetic Impact in the Eye</article-title><source>Eur. J. Pharm. Sci.</source><year>2018</year><volume>119</volume><fpage>83</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1016/j.ejps.2018.03.034</pub-id><pub-id pub-id-type="pmid">29625211</pub-id>
</element-citation></ref><ref id="B37-pharmaceutics-17-00156"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Worth</surname><given-names>A.P.</given-names></name>
<name><surname>Cronin</surname><given-names>M.T.D.</given-names></name>
</person-group><article-title>Structure-Permeability Relationships for Transcorneal Penetration</article-title><source>Atla-Altern. Lab. Anim.</source><year>2000</year><volume>28</volume><fpage>403</fpage><lpage>413</lpage><pub-id pub-id-type="doi">10.1177/026119290002800318</pub-id><pub-id pub-id-type="pmid">25419921</pub-id>
</element-citation></ref><ref id="B38-pharmaceutics-17-00156"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fu</surname><given-names>X.C.</given-names></name>
<name><surname>Liang</surname><given-names>W.Q.Q.</given-names></name>
</person-group><article-title>A Simple Model for the Prediction of Corneal Permeability</article-title><source>Int. J. Pharm.</source><year>2002</year><volume>232</volume><fpage>193</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/S0378-5173(01)00902-4</pub-id><pub-id pub-id-type="pmid">11790503</pub-id>
</element-citation></ref><ref id="B39-pharmaceutics-17-00156"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yoshida</surname><given-names>F.</given-names></name>
<name><surname>Topliss</surname><given-names>J.G.</given-names></name>
</person-group><article-title>Unified Model for the Corneal Permeability of Related and Diverse Compounds with Respect to Their Physicochemical Properties</article-title><source>J. Pharm. Sci.</source><year>1996</year><volume>85</volume><fpage>819</fpage><lpage>823</lpage><pub-id pub-id-type="doi">10.1021/js960076m</pub-id><pub-id pub-id-type="pmid">8863270</pub-id>
</element-citation></ref><ref id="B40-pharmaceutics-17-00156"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kidron</surname><given-names>H.</given-names></name>
<name><surname>Vellonen</surname><given-names>K.S.</given-names></name>
<name><surname>del Amo</surname><given-names>E.M.</given-names></name>
<name><surname>Tissari</surname><given-names>A.</given-names></name>
<name><surname>Urtti</surname><given-names>A.</given-names></name>
</person-group><article-title>Prediction of the Corneal Permeability of Drug-Like Compounds</article-title><source>Pharm. Res.</source><year>2010</year><volume>27</volume><fpage>1398</fpage><lpage>1407</lpage><pub-id pub-id-type="doi">10.1007/s11095-010-0132-8</pub-id><pub-id pub-id-type="pmid">20387098</pub-id>
</element-citation></ref><ref id="B41-pharmaceutics-17-00156"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Patel</surname><given-names>S.</given-names></name>
<name><surname>Galor</surname><given-names>A.</given-names></name>
</person-group><article-title>Editorial: The Impact of Clinical and Environmental Toxicological Exposures and Eye Health</article-title><source>Front. Toxicol.</source><year>2024</year><volume>6</volume><elocation-id>1344052</elocation-id><pub-id pub-id-type="doi">10.3389/ftox.2024.1344052</pub-id><pub-id pub-id-type="pmid">38454983</pub-id>
</element-citation></ref><ref id="B42-pharmaceutics-17-00156"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rauchman</surname><given-names>S.H.</given-names></name>
<name><surname>Kasselman</surname><given-names>L.J.</given-names></name>
<name><surname>Srivastava</surname><given-names>A.</given-names></name>
<name><surname>De Leon</surname><given-names>J.</given-names></name>
<name><surname>Reiss</surname><given-names>A.B.</given-names></name>
</person-group><article-title>An Assessment of the Ocular Toxicity of Two Major Sources of Environmental Exposure</article-title><source>Int. J. Environ. Res. Public Health</source><year>2024</year><volume>21</volume><elocation-id>780</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph21060780</pub-id><pub-id pub-id-type="pmid">38929026</pub-id>
</element-citation></ref><ref id="B43-pharmaceutics-17-00156"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rauchman</surname><given-names>S.H.</given-names></name>
<name><surname>Locke</surname><given-names>B.</given-names></name>
<name><surname>Albert</surname><given-names>J.</given-names></name>
<name><surname>De Leon</surname><given-names>J.</given-names></name>
<name><surname>Peltier</surname><given-names>M.R.</given-names></name>
<name><surname>Reiss</surname><given-names>A.B.</given-names></name>
</person-group><article-title>Toxic External Exposure Leading to Ocular Surface Injury</article-title><source>Vision</source><year>2023</year><volume>7</volume><elocation-id>32</elocation-id><pub-id pub-id-type="doi">10.3390/vision7020032</pub-id><pub-id pub-id-type="pmid">37092465</pub-id>
</element-citation></ref><ref id="B44-pharmaceutics-17-00156"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jaga</surname><given-names>K.</given-names></name>
<name><surname>Dharmani</surname><given-names>C.</given-names></name>
</person-group><article-title>Ocular Toxicity from Pesticide Exposure: A Recent Review</article-title><source>Environ. Health Prev. Med.</source><year>2006</year><volume>11</volume><fpage>102</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1265/ehpm.11.102</pub-id><pub-id pub-id-type="pmid">21432383</pub-id>
</element-citation></ref><ref id="B45-pharmaceutics-17-00156"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>Q.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Yang</surname><given-names>H.</given-names></name>
<name><surname>Cai</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>Z.</given-names></name>
<name><surname>Li</surname><given-names>W.</given-names></name>
<name><surname>Tang</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>G.</given-names></name>
</person-group><article-title>In Silico Prediction of Serious Eye Irritation or Corrosion Potential of Chemicals</article-title><source>RCS Adv.</source><year>2017</year><volume>7</volume><fpage>6697</fpage><lpage>6703</lpage><pub-id pub-id-type="doi">10.1039/C6RA25267B</pub-id></element-citation></ref><ref id="B46-pharmaceutics-17-00156"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hall</surname><given-names>L.H.</given-names></name>
<name><surname>Kier</surname><given-names>L.B.</given-names></name>
</person-group><article-title>Electrotopological State Indices for Atom Types: A Novel Combination of Electronic, Topological, and Valence State Information</article-title><source>J. Chem. Inf. Comput. Sci.</source><year>1995</year><volume>35</volume><fpage>1039</fpage><lpage>1045</lpage><pub-id pub-id-type="doi">10.1021/ci00028a014</pub-id></element-citation></ref><ref id="B47-pharmaceutics-17-00156"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hall</surname><given-names>L.H.</given-names></name>
<name><surname>Kier</surname><given-names>L.B.</given-names></name>
<name><surname>Brown</surname><given-names>B.B.</given-names></name>
</person-group><article-title>Molecular Similarity Based on Novel Atom-Type Electrotopological State Indices</article-title><source>J. Chem. Inf. Comput. Sci.</source><year>1995</year><volume>35</volume><fpage>1074</fpage><lpage>1080</lpage><pub-id pub-id-type="doi">10.1021/ci00028a019</pub-id></element-citation></ref><ref id="B48-pharmaceutics-17-00156"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Daina</surname><given-names>A.</given-names></name>
<name><surname>Michielin</surname><given-names>O.</given-names></name>
<name><surname>Zoete</surname><given-names>V.</given-names></name>
</person-group><article-title>SwissADME: A Free Web Tool to Evaluate Pharmacokinetics, Drug-Likeness and Medicinal Chemistry Friendliness of Small Molecules</article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><elocation-id>42717</elocation-id><pub-id pub-id-type="doi">10.1038/srep42717</pub-id><pub-id pub-id-type="pmid">28256516</pub-id>
</element-citation></ref><ref id="B49-pharmaceutics-17-00156"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fu</surname><given-names>L.</given-names></name>
<name><surname>Shi</surname><given-names>S.</given-names></name>
<name><surname>Yi</surname><given-names>J.</given-names></name>
<name><surname>Wang</surname><given-names>N.</given-names></name>
<name><surname>He</surname><given-names>Y.</given-names></name>
<name><surname>Wu</surname><given-names>Z.</given-names></name>
<name><surname>Peng</surname><given-names>J.</given-names></name>
<name><surname>Deng</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>W.</given-names></name>
<name><surname>Wu</surname><given-names>C.</given-names></name>
<etal/>
</person-group><article-title>ADMETlab 3.0: An Updated Comprehensive Online ADMET Prediction Platform Enhanced with Broader Coverage, Improved Performance, API Functionality and Decision Support</article-title><source>Nucleic Acids Res.</source><year>2024</year><volume>52</volume><fpage>W422</fpage><lpage>W431</lpage><pub-id pub-id-type="doi">10.1093/nar/gkae236</pub-id><pub-id pub-id-type="pmid">38572755</pub-id>
</element-citation></ref><ref id="B50-pharmaceutics-17-00156"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gramatica</surname><given-names>P.</given-names></name>
</person-group><article-title>On the Development and Validation of QSAR Models</article-title><source>Methods Mol. Biol.</source><year>2013</year><volume>930</volume><fpage>499</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1007/978-1-62703-059-5_21</pub-id><pub-id pub-id-type="pmid">23086855</pub-id>
</element-citation></ref><ref id="B51-pharmaceutics-17-00156"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Golbraikh</surname><given-names>A.</given-names></name>
<name><surname>Tropsha</surname><given-names>A.</given-names></name>
</person-group><article-title>Beware of Q2!</article-title><source>J. Mol. Graph. Model.</source><year>2002</year><volume>20</volume><fpage>269</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1016/S1093-3263(01)00123-1</pub-id><pub-id pub-id-type="pmid">11858635</pub-id>
</element-citation></ref><ref id="B52-pharmaceutics-17-00156"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Potts</surname><given-names>R.O.</given-names></name>
<name><surname>Guy</surname><given-names>R.H.</given-names></name>
</person-group><article-title>Predicting Skin Permeability</article-title><source>Pharm. Res.</source><year>1992</year><volume>9</volume><fpage>663</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.1023/A:1015810312465</pub-id><pub-id pub-id-type="pmid">1608900</pub-id>
</element-citation></ref><ref id="B53-pharmaceutics-17-00156"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Potts</surname><given-names>R.O.</given-names></name>
<name><surname>Guy</surname><given-names>R.H.</given-names></name>
</person-group><article-title>A Predictive Algorithm for Skin Permeability: The Effects of Molecular Size and Hydrogen Bond Activity</article-title><source>Pharm. Res.</source><year>1995</year><volume>12</volume><fpage>1628</fpage><lpage>1633</lpage><pub-id pub-id-type="doi">10.1023/A:1016236932339</pub-id><pub-id pub-id-type="pmid">8592661</pub-id>
</element-citation></ref><ref id="B54-pharmaceutics-17-00156"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sugano</surname><given-names>K.</given-names></name>
<name><surname>Kansy</surname><given-names>M.</given-names></name>
<name><surname>Artursson</surname><given-names>P.</given-names></name>
<name><surname>Avdeef</surname><given-names>A.</given-names></name>
<name><surname>Bendels</surname><given-names>S.</given-names></name>
<name><surname>Di</surname><given-names>L.</given-names></name>
<name><surname>Ecker</surname><given-names>G.F.</given-names></name>
<name><surname>Faller</surname><given-names>B.</given-names></name>
<name><surname>Fischer</surname><given-names>H.</given-names></name>
<name><surname>Gerebtzoff</surname><given-names>G.</given-names></name>
<etal/>
</person-group><article-title>Coexistence of Passive and Carrier-Mediated Processes in Drug Transport</article-title><source>Nat. Rev. Drug Discov.</source><year>2010</year><volume>9</volume><fpage>597</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1038/nrd3187</pub-id><pub-id pub-id-type="pmid">20671764</pub-id>
</element-citation></ref><ref id="B55-pharmaceutics-17-00156"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fernandes</surname><given-names>G.S.</given-names></name>
<name><surname>Pereira</surname><given-names>M.B.</given-names></name>
</person-group><article-title>de M.; Marinho, A.C.B.; Machado, B.; Moreira, A.C.; Freitas, M.P. de; Lang, K.L.; Antunes, J.E. In Silico Pharmacokinetics Studies for Quinazolines Proposed as EGFR Inhibitors</article-title><source>Open J. Med. Chem.</source><year>2015</year><volume>5</volume><fpage>106</fpage><lpage>115</lpage><pub-id pub-id-type="doi">10.4236/ojmc.2015.54007</pub-id></element-citation></ref><ref id="B56-pharmaceutics-17-00156"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arnot</surname><given-names>J.A.</given-names></name>
<name><surname>Gobas</surname><given-names>F.A.P.C.</given-names></name>
</person-group><article-title>A Review of Bioconcentration Factor (BCF) and Bioaccumulation Factor (BAF) Assessments for Organic Chemicals in Aquatic Organisms</article-title><source>Environ. Rev.</source><year>2006</year><volume>14</volume><fpage>257</fpage><lpage>297</lpage><pub-id pub-id-type="doi">10.1139/a06-005</pub-id></element-citation></ref><ref id="B57-pharmaceutics-17-00156"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Meylan</surname><given-names>W.M.</given-names></name>
<name><surname>Howard</surname><given-names>P.H.</given-names></name>
<name><surname>Boethling</surname><given-names>R.S.</given-names></name>
<name><surname>Aronson</surname><given-names>D.</given-names></name>
<name><surname>Printup</surname><given-names>H.</given-names></name>
<name><surname>Gouchie</surname><given-names>S.</given-names></name>
</person-group><article-title>Improved Method for Estimating Bioconcentration/Bioaccumulation Factor from Octanol/Water Partition Coefficient</article-title><source>Environ. Toxicol. Chem.</source><year>1999</year><volume>18</volume><fpage>664</fpage><lpage>672</lpage><pub-id pub-id-type="doi">10.1002/etc.5620180412</pub-id></element-citation></ref><ref id="B58-pharmaceutics-17-00156"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dimitrov</surname><given-names>S.D.</given-names></name>
<name><surname>Dimitrova</surname><given-names>N.C.</given-names></name>
<name><surname>Walker</surname><given-names>J.D.</given-names></name>
<name><surname>Veith</surname><given-names>G.D.</given-names></name>
<name><surname>Mekenyan</surname><given-names>O.G.</given-names></name>
</person-group><article-title>Predicting Bioconcentration Factors of Highly Hydrophobic Chemicals. Effects of Molecular Size</article-title><source>Pure Appl. Chem.</source><year>2002</year><volume>74</volume><fpage>1823</fpage><lpage>1830</lpage><pub-id pub-id-type="doi">10.1351/pac200274101823</pub-id></element-citation></ref><ref id="B59-pharmaceutics-17-00156"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clark</surname><given-names>D.E.</given-names></name>
</person-group><article-title>Rapid Calculation of Polar Molecular Surface Area and Its Application to the Prediction of Transport Phenomena. 2. Prediction of Blood-Brain Barrier Penetration</article-title><source>J. Pharm. Sci.</source><year>1999</year><volume>88</volume><fpage>815</fpage><lpage>821</lpage><pub-id pub-id-type="doi">10.1021/js980402t</pub-id><pub-id pub-id-type="pmid">10430548</pub-id>
</element-citation></ref><ref id="B60-pharmaceutics-17-00156"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Janicka</surname><given-names>M.</given-names></name>
<name><surname>Sztanke</surname><given-names>M.</given-names></name>
<name><surname>Sztanke</surname><given-names>K.</given-names></name>
</person-group><article-title>Predicting the Blood-Brain Barrier Permeability of New Drug-Like Compounds via HPLC with Various Stationary Phases</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>487</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25030487</pub-id><pub-id pub-id-type="pmid">31979316</pub-id>
</element-citation></ref><ref id="B61-pharmaceutics-17-00156"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Soba&#x00144;ska</surname><given-names>A.W.</given-names></name>
<name><surname>Brzezi&#x00144;ska</surname><given-names>E.</given-names></name>
</person-group><article-title>IAM Chromatographic Models of Skin Permeation</article-title><source>Molecules</source><year>2022</year><volume>27</volume><elocation-id>1893</elocation-id><pub-id pub-id-type="doi">10.3390/molecules27061893</pub-id><pub-id pub-id-type="pmid">35335257</pub-id>
</element-citation></ref><ref id="B62-pharmaceutics-17-00156"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hubatsch</surname><given-names>I.</given-names></name>
<name><surname>Ragnarsson</surname><given-names>E.G.E.</given-names></name>
<name><surname>Artursson</surname><given-names>P.</given-names></name>
</person-group><article-title>Determination of Drug Permeability and Prediction of Drug Absorption in Caco-2 Monolayers</article-title><source>Nat. Protoc.</source><year>2007</year><volume>2</volume><fpage>2111</fpage><lpage>2119</lpage><pub-id pub-id-type="doi">10.1038/nprot.2007.303</pub-id><pub-id pub-id-type="pmid">17853866</pub-id>
</element-citation></ref><ref id="B63-pharmaceutics-17-00156"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Van Breemen</surname><given-names>R.B.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
</person-group><article-title>Caco-2cell Permeability Assays to Measure Drug Absorption</article-title><source>Expert Opin. Drug Metab. Toxicol.</source><year>2005</year><volume>1</volume><fpage>175</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1517/17425255.1.2.175</pub-id><pub-id pub-id-type="pmid">16922635</pub-id>
</element-citation></ref><ref id="B64-pharmaceutics-17-00156"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Irvine</surname><given-names>J.D.</given-names></name>
<name><surname>Takahashi</surname><given-names>L.</given-names></name>
<name><surname>Lockhar</surname><given-names>K.</given-names></name>
<name><surname>Cheong</surname><given-names>J.</given-names></name>
<name><surname>Tolan</surname><given-names>J.W.</given-names></name>
<name><surname>SelickK</surname><given-names>H.E.</given-names></name>
<name><surname>Grove</surname><given-names>J.R.</given-names></name>
</person-group><article-title>MDCK (Madin&#x02212;Darby Canine Kidney) Cells: A Tool for Membrane Permeability Screening</article-title><source>J. Pharm. Sci.</source><year>2012</year><volume>88</volume><fpage>28</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1021/js9803205</pub-id></element-citation></ref><ref id="B65-pharmaceutics-17-00156"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hellinger</surname><given-names>&#x000c9;.</given-names></name>
<name><surname>Veszelka</surname><given-names>S.</given-names></name>
<name><surname>T&#x000f3;th</surname><given-names>A.E.</given-names></name>
<name><surname>Walter</surname><given-names>F.</given-names></name>
<name><surname>Kittel</surname><given-names>&#x000c1;.</given-names></name>
<name><surname>Bakk</surname><given-names>M.L.</given-names></name>
<name><surname>Tihanyi</surname><given-names>K.</given-names></name>
<name><surname>H&#x000e1;da</surname><given-names>V.</given-names></name>
<name><surname>Nakagawa</surname><given-names>S.</given-names></name>
<name><surname>Dinh Ha Duy</surname><given-names>T.</given-names></name>
<etal/>
</person-group><article-title>Comparison of Brain Capillary Endothelial Cell-Based and Epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) Cell-Based Surrogate Blood-Brain Barrier Penetration Models</article-title><source>Eur. J. Pharm. Biopharm.</source><year>2012</year><volume>82</volume><fpage>340</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1016/j.ejpb.2012.07.020</pub-id><pub-id pub-id-type="pmid">22906709</pub-id>
</element-citation></ref><ref id="B66-pharmaceutics-17-00156"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jin</surname><given-names>X.</given-names></name>
<name><surname>Luong</surname><given-names>T.L.</given-names></name>
<name><surname>Reese</surname><given-names>N.</given-names></name>
<name><surname>Gaona</surname><given-names>H.</given-names></name>
<name><surname>Collazo-Velez</surname><given-names>V.</given-names></name>
<name><surname>Vuong</surname><given-names>C.</given-names></name>
<name><surname>Potter</surname><given-names>B.</given-names></name>
<name><surname>Sousa</surname><given-names>J.C.</given-names></name>
<name><surname>Olmeda</surname><given-names>R.</given-names></name>
<name><surname>Li</surname><given-names>Q.</given-names></name>
<etal/>
</person-group><article-title>Comparison of MDCK-MDR1 and Caco-2 Cell Based Permeability Assays for Anti-Malarial Drug Screening and Drug Investigations</article-title><source>J. Pharmacol. Toxicol. Methods</source><year>2014</year><volume>70</volume><fpage>188</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1016/j.vascn.2014.08.002</pub-id><pub-id pub-id-type="pmid">25150934</pub-id>
</element-citation></ref><ref id="B67-pharmaceutics-17-00156"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lipinski</surname><given-names>C.A.</given-names></name>
</person-group><article-title>Lead- and Drug-like Compounds: The Rule-of-Five Revolution</article-title><source>Drug Discov. Today Technol.</source><year>2004</year><volume>1</volume><fpage>337</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1016/j.ddtec.2004.11.007</pub-id><pub-id pub-id-type="pmid">24981612</pub-id>
</element-citation></ref><ref id="B68-pharmaceutics-17-00156"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lipinski</surname><given-names>C.A.</given-names></name>
</person-group><article-title>Rule of Five in 2015 and beyond: Target and Ligand Structural Limitations, Ligand Chemistry Structure and Drug Discovery Project Decisions</article-title><source>Adv. Drug Deliv. Rev.</source><year>2016</year><volume>101</volume><fpage>34</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.addr.2016.04.029</pub-id><pub-id pub-id-type="pmid">27154268</pub-id>
</element-citation></ref><ref id="B69-pharmaceutics-17-00156"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Soba&#x00144;ska</surname><given-names>A.W.</given-names></name>
</person-group><article-title>In Silico Assessment of Risks Associated with Pesticides Exposure during Pregnancy</article-title><source>Chemosphere</source><year>2023</year><volume>329</volume><fpage>138649</fpage><pub-id pub-id-type="doi">10.1016/j.chemosphere.2023.138649</pub-id><pub-id pub-id-type="pmid">37043889</pub-id>
</element-citation></ref><ref id="B70-pharmaceutics-17-00156"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Luechtefeld</surname><given-names>T.</given-names></name>
<name><surname>Maertens</surname><given-names>A.</given-names></name>
<name><surname>Russo</surname><given-names>D.P.</given-names></name>
<name><surname>Rovida</surname><given-names>C.</given-names></name>
<name><surname>Hartung</surname><given-names>T.</given-names></name>
<name><surname>Sciences</surname><given-names>E.H.</given-names></name>
<name><surname>Biology</surname><given-names>I.</given-names></name>
</person-group><article-title>Analysis of Draize Eye Irritation Testing and Its Prediction by Mining Publicly Available 2008&#x02013;2014 REACH Data</article-title><source>ALTEX Altern. Anim. Exp.</source><year>2016</year><volume>33</volume><fpage>123</fpage><lpage>134</lpage><pub-id pub-id-type="doi">10.14573/altex.1510053</pub-id><pub-id pub-id-type="pmid">26863293</pub-id>
</element-citation></ref><ref id="B71-pharmaceutics-17-00156"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sp&#x000f6;ler</surname><given-names>F.</given-names></name>
<name><surname>Kray</surname><given-names>O.</given-names></name>
<name><surname>Kray</surname><given-names>S.</given-names></name>
<name><surname>Panfil</surname><given-names>C.</given-names></name>
<name><surname>Schrage</surname><given-names>N.F.</given-names></name>
</person-group><article-title>The Ex Vivo Eye Irritation Test as an Alternative Test Method for Serious Eye Damage/Eye Irritation</article-title><source>ATLA Altern. Lab. Anim.</source><year>2015</year><volume>43</volume><fpage>163</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1177/026119291504300306</pub-id><pub-id pub-id-type="pmid">26256395</pub-id>
</element-citation></ref><ref id="B72-pharmaceutics-17-00156"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tandon</surname><given-names>R.</given-names></name>
<name><surname>Bartok</surname><given-names>M.</given-names></name>
<name><surname>Zorn-Kruppa</surname><given-names>M.</given-names></name>
<name><surname>Brandner</surname><given-names>J.M.</given-names></name>
<name><surname>Gabel</surname><given-names>D.</given-names></name>
<name><surname>Engelke</surname><given-names>M.</given-names></name>
</person-group><article-title>Assessment of the Eye Irritation Potential of Chemicals: A Comparison Study between Two Test Methods Based on Human 3D Hemi-Cornea Models</article-title><source>Toxicol. In Vitro</source><year>2015</year><volume>30</volume><fpage>561</fpage><lpage>568</lpage><pub-id pub-id-type="doi">10.1016/j.tiv.2015.09.003</pub-id><pub-id pub-id-type="pmid">26362509</pub-id>
</element-citation></ref><ref id="B73-pharmaceutics-17-00156"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kulkarni</surname><given-names>A.</given-names></name>
<name><surname>Hopfinger</surname><given-names>A.J.</given-names></name>
<name><surname>Osborne</surname><given-names>R.</given-names></name>
<name><surname>Bruner</surname><given-names>L.H.</given-names></name>
<name><surname>Thompson</surname><given-names>E.D.</given-names></name>
</person-group><article-title>Prediction of Eye Irritation from Organic Chemicals Using Membrane-Interaction QSAR Analysis</article-title><source>Toxicol. Sci.</source><year>2001</year><volume>59</volume><fpage>335</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1093/toxsci/59.2.335</pub-id><pub-id pub-id-type="pmid">11158727</pub-id>
</element-citation></ref><ref id="B74-pharmaceutics-17-00156"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bagley</surname><given-names>D.M.</given-names></name>
<name><surname>Gardner</surname><given-names>J.R.</given-names></name>
<name><surname>Holland</surname><given-names>G.</given-names></name>
<name><surname>Lewis</surname><given-names>R.W.</given-names></name>
<name><surname>Vrijhof</surname><given-names>H.</given-names></name>
<name><surname>Walker</surname><given-names>A.P.</given-names></name>
</person-group><article-title>Eye Irritation: Updated Reference Chemicals Data Bank</article-title><source>Toxicol. In Vitro</source><year>1999</year><volume>13</volume><fpage>505</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1016/S0887-2333(99)00015-6</pub-id><pub-id pub-id-type="pmid">20654508</pub-id>
</element-citation></ref><ref id="B75-pharmaceutics-17-00156"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Toropov</surname><given-names>A.A.</given-names></name>
<name><surname>Toropova</surname><given-names>A.P.</given-names></name>
<name><surname>Roncaglioni</surname><given-names>A.</given-names></name>
<name><surname>Benfenati</surname><given-names>E.</given-names></name>
</person-group><article-title>Semi-Correlations for Building Up a Simulation of Eye Irritation</article-title><source>Toxics</source><year>2023</year><volume>11</volume><elocation-id>993</elocation-id><pub-id pub-id-type="doi">10.3390/toxics11120993</pub-id><pub-id pub-id-type="pmid">38133394</pub-id>
</element-citation></ref><ref id="B76-pharmaceutics-17-00156"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saliner</surname><given-names>A.G.</given-names></name>
<name><surname>Patlewicz</surname><given-names>G.</given-names></name>
<name><surname>Worth</surname><given-names>A.P.</given-names></name>
</person-group><article-title>A Review of (Q)SAR Models for Skin and Eye Irritation and Corrosion</article-title><source>QSAR Comb. Sci.</source><year>2008</year><volume>27</volume><fpage>49</fpage><lpage>59</lpage><pub-id pub-id-type="doi">10.1002/qsar.200710103</pub-id></element-citation></ref><ref id="B77-pharmaceutics-17-00156"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abraham</surname><given-names>M.H.</given-names></name>
<name><surname>Kumarsingh</surname><given-names>R.</given-names></name>
<name><surname>Cometto-Muniz</surname><given-names>J.E.</given-names></name>
<name><surname>Cain</surname><given-names>W.S.</given-names></name>
</person-group><article-title>A Quantitative Structure-Activity Relationship (QSAR) for a Draize Eye Irritation Database</article-title><source>Toxicol. In Vitro</source><year>1998</year><volume>12</volume><fpage>201</fpage><lpage>207</lpage><pub-id pub-id-type="doi">10.1016/S0887-2333(97)00117-3</pub-id><pub-id pub-id-type="pmid">20654402</pub-id>
</element-citation></ref><ref id="B78-pharmaceutics-17-00156"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barratt</surname><given-names>M.D.</given-names></name>
</person-group><article-title>A Quantitative Structure-Activity Relationship for the Eye Irritation Potential of Neutral Organic Chemicals</article-title><source>Toxicol. Lett.</source><year>1995</year><volume>80</volume><fpage>69</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/0378-4274(95)03338-L</pub-id><pub-id pub-id-type="pmid">7482594</pub-id>
</element-citation></ref><ref id="B79-pharmaceutics-17-00156"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gerner</surname><given-names>I.</given-names></name>
<name><surname>Liebsch</surname><given-names>M.</given-names></name>
<name><surname>Spielmann</surname><given-names>H.</given-names></name>
</person-group><article-title>Assessment of the Eye Irritating Properties of Chemicals by Applying Alternatives to the Draize Rabbit Eye Test: The Use of QSARs and In Vitro Tests for the Classification of Eye Irritation</article-title><source>ATLA Altern. Lab. Anim.</source><year>2005</year><volume>33</volume><fpage>215</fpage><lpage>237</lpage><pub-id pub-id-type="doi">10.1177/026119290503300307</pub-id><pub-id pub-id-type="pmid">16180977</pub-id>
</element-citation></ref><ref id="B80-pharmaceutics-17-00156"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>J.</given-names></name>
<name><surname>Pan</surname><given-names>D.</given-names></name>
<name><surname>Hopfinger</surname><given-names>A.J.</given-names></name>
</person-group><article-title>A Study of the Relationship between Cornea Permeability and Eye Irritation Using Membrane-Interaction QSAR Analysis</article-title><source>Toxicol. Sci.</source><year>2005</year><volume>88</volume><fpage>434</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1093/toxsci/kfi319</pub-id><pub-id pub-id-type="pmid">16162848</pub-id>
</element-citation></ref><ref id="B81-pharmaceutics-17-00156"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Verstraelen</surname><given-names>S.</given-names></name>
<name><surname>Jacobs</surname><given-names>A.</given-names></name>
<name><surname>De Wever</surname><given-names>B.</given-names></name>
<name><surname>Vanparys</surname><given-names>P.</given-names></name>
</person-group><article-title>Improvement of the Bovine Corneal Opacity and Permeability (BCOP) Assay as an in Vitro Alternative to the Draize Rabbit Eye Irritation Test</article-title><source>Toxicol. In Vitro</source><year>2013</year><volume>27</volume><fpage>1298</fpage><lpage>1311</lpage><pub-id pub-id-type="doi">10.1016/j.tiv.2013.02.018</pub-id><pub-id pub-id-type="pmid">23501624</pub-id>
</element-citation></ref><ref id="B82-pharmaceutics-17-00156"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hayashi</surname><given-names>K.</given-names></name>
<name><surname>Mori</surname><given-names>T.</given-names></name>
<name><surname>Abo</surname><given-names>T.</given-names></name>
<name><surname>Koike</surname><given-names>M.</given-names></name>
<name><surname>Takahashi</surname><given-names>Y.</given-names></name>
<name><surname>Sakaguchi</surname><given-names>H.</given-names></name>
<name><surname>Nishiyama</surname><given-names>N.</given-names></name>
</person-group><article-title>A Tiered Approach Combining the Short Time Exposure (STE) Test and the Bovine Corneal Opacity and Permeability (BCOP) Assay for Predicting Eye Irritation Potential of Chemicals</article-title><source>J. Toxicol. Sci.</source><year>2012</year><volume>37</volume><fpage>269</fpage><lpage>280</lpage><pub-id pub-id-type="doi">10.2131/jts.37.269</pub-id><pub-id pub-id-type="pmid">22467017</pub-id>
</element-citation></ref><ref id="B83-pharmaceutics-17-00156"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Solimeo</surname><given-names>R.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Kim</surname><given-names>M.</given-names></name>
<name><surname>Sedykh</surname><given-names>A.</given-names></name>
<name><surname>Zhu</surname><given-names>H.</given-names></name>
</person-group><article-title>Predicting Chemical Ocular Toxicity Using a Combinatorial QSAR Approach</article-title><source>Chem. Res. Toxicol.</source><year>2012</year><volume>25</volume><fpage>2763</fpage><lpage>2769</lpage><pub-id pub-id-type="doi">10.1021/tx300393v</pub-id><pub-id pub-id-type="pmid">23148656</pub-id>
</element-citation></ref><ref id="B84-pharmaceutics-17-00156"><label>84.</label><element-citation publication-type="gov"><article-title>Globally Harmonized System of Classification and Labelling of Chemicals (Rev. 9, 2021)</article-title><comment>Available online: <ext-link xlink:href="https://pubchem.ncbi.nlm.nih.gov/ghs/ghs_9.html" ext-link-type="uri">https://pubchem.ncbi.nlm.nih.gov/ghs/ghs_9.html</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-01-16">(accessed on 16 January 2025)</date-in-citation></element-citation></ref></ref-list></back><floats-group><fig position="float" id="pharmaceutics-17-00156-f001"><label>Figure 1</label><caption><p>Predicted vs. observed log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> for compounds <bold>1</bold> to <bold>90</bold>&#x02014;Equation (8).</p></caption><graphic xlink:href="pharmaceutics-17-00156-g001" position="float"/></fig><fig position="float" id="pharmaceutics-17-00156-f002"><label>Figure 2</label><caption><p>Predicted vs. observed log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> for compounds <bold>1</bold> to <bold>90</bold>&#x02014;Equation (9).</p></caption><graphic xlink:href="pharmaceutics-17-00156-g002" position="float"/></fig><fig position="float" id="pharmaceutics-17-00156-f003"><label>Figure 3</label><caption><p>Predicted vs. observed log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> for compounds <bold>1</bold> to <bold>90</bold>&#x02014;Equation (14).</p></caption><graphic xlink:href="pharmaceutics-17-00156-g003" position="float"/></fig><fig position="float" id="pharmaceutics-17-00156-f004"><label>Figure 4</label><caption><p>Predicted vs. observed log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> for compounds <bold>1</bold> to <bold>90</bold>&#x02014;Equation (15)<bold>.</bold></p></caption><graphic xlink:href="pharmaceutics-17-00156-g004" position="float"/></fig><fig position="float" id="pharmaceutics-17-00156-f005"><label>Figure 5</label><caption><p>Predicted vs. observed log <bold><italic toggle="yes">K</italic></bold><sub>corn</sub> for compounds <bold>1</bold> to <bold>90</bold>&#x02014;Equation (16).</p></caption><graphic xlink:href="pharmaceutics-17-00156-g005" position="float"/></fig><table-wrap position="float" id="pharmaceutics-17-00156-t001"><object-id pub-id-type="pii">pharmaceutics-17-00156-t001_Table 1</object-id><label>Table 1</label><caption><p>Classification summary (MLP 12-13-2; training algorithm BFGS 50; error function&#x02014;entropy; hidden activation&#x02014;Tanh; output activation&#x02014;Softmax).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin" rowspan="1">Training</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin" rowspan="1">Test</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin" rowspan="1">Validation</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin" rowspan="1">Total</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Class-0</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Class-1</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Class-0</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Class-1</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Class-0</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Class-1</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Class-0</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Class-1</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Class-All</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Total</td><td align="center" valign="middle" rowspan="1" colspan="1">994</td><td align="center" valign="middle" rowspan="1" colspan="1">617</td><td align="center" valign="middle" rowspan="1" colspan="1">210</td><td align="center" valign="middle" rowspan="1" colspan="1">134</td><td align="center" valign="middle" rowspan="1" colspan="1">208</td><td align="center" valign="middle" rowspan="1" colspan="1">136</td><td align="center" valign="middle" rowspan="1" colspan="1">1412</td><td align="center" valign="middle" rowspan="1" colspan="1">887</td><td align="center" valign="middle" rowspan="1" colspan="1">2299</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Correct</td><td align="center" valign="middle" rowspan="1" colspan="1">964</td><td align="center" valign="middle" rowspan="1" colspan="1">592</td><td align="center" valign="middle" rowspan="1" colspan="1">200</td><td align="center" valign="middle" rowspan="1" colspan="1">129</td><td align="center" valign="middle" rowspan="1" colspan="1">200</td><td align="center" valign="middle" rowspan="1" colspan="1">132</td><td align="center" valign="middle" rowspan="1" colspan="1">1364</td><td align="center" valign="middle" rowspan="1" colspan="1">853</td><td align="center" valign="middle" rowspan="1" colspan="1">2217</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Incorrect</td><td align="center" valign="middle" rowspan="1" colspan="1">30</td><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td><td align="center" valign="middle" rowspan="1" colspan="1">5</td><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">4</td><td align="center" valign="middle" rowspan="1" colspan="1">48</td><td align="center" valign="middle" rowspan="1" colspan="1">34</td><td align="center" valign="middle" rowspan="1" colspan="1">82</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Correct (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">97.0</td><td align="center" valign="middle" rowspan="1" colspan="1">95.9</td><td align="center" valign="middle" rowspan="1" colspan="1">95.2</td><td align="center" valign="middle" rowspan="1" colspan="1">96.3</td><td align="center" valign="middle" rowspan="1" colspan="1">96.2</td><td align="center" valign="middle" rowspan="1" colspan="1">97.1</td><td align="center" valign="middle" rowspan="1" colspan="1">96.6</td><td align="center" valign="middle" rowspan="1" colspan="1">96.2</td><td align="center" valign="middle" rowspan="1" colspan="1">96.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Incorrect (%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.6</td></tr></tbody></table></table-wrap></floats-group></article>